{"gene":"NFATC4","run_date":"2026-04-29T11:37:56","timeline":{"discoveries":[{"year":1999,"finding":"NFATc4 undergoes calcineurin-dependent nuclear translocation in hippocampal neurons in response to electrical activity or K+ depolarization, specifically requiring calcium entry through L-type voltage-gated calcium channels. GSK-3 phosphorylates NFATc4, promoting its nuclear export and antagonizing NFATc4-dependent transcription. NFATc4 controls expression of the inositol 1,4,5-trisphosphate receptor type 1 gene.","method":"Live imaging of NFATc4-GFP translocation in neurons, pharmacological inhibition of L-type channels, GSK-3 kinase assays, calcineurin inhibitor (cyclosporin A/FK506) treatment, reporter gene assays","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (imaging, pharmacology, kinase assay, reporter), replicated across stimulation conditions, highly cited foundational paper","pmids":["10537109"],"is_preprint":false},{"year":2002,"finding":"p38 MAP kinase phosphorylates NFATc4 at multiple residues including Ser168 and Ser170 within the NFAT homology domain. Phosphorylation at these sites promotes cytoplasmic retention; Ala168/170 substitutions promote nuclear localization, increase NFAT-mediated transcription, and drive adipocyte differentiation by activating PPARγ2 gene expression via direct NFAT binding elements in the PPARγ2 promoter.","method":"In vitro kinase assay, site-directed mutagenesis, stable cell line expression, reporter assays, adipocyte differentiation assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 — in vitro kinase assay combined with mutagenesis and functional cellular readouts in a single study","pmids":["11997522"],"is_preprint":false},{"year":2001,"finding":"NFATc4 contains two distinct transactivation domains (N-terminal and C-terminal) that each interact with separate regions of the coactivator CBP (KIX and CH3 domains respectively). Both transactivation domains are required for CBP-mediated potentiation of NFATc4 transcriptional activity; removal of either domain abolishes CBP potentiation.","method":"Co-immunoprecipitation, deletion mutagenesis, reporter gene assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — reciprocal binding mapped to defined domains with mutagenesis and functional transcription assays","pmids":["11514544"],"is_preprint":false},{"year":2005,"finding":"The ERK/RSK signaling pathway is recruited to the NFATc4-DNA transcription complex. RSK phosphorylates NFATc4 at Ser676, potentiating NFATc4 DNA binding by increasing NFAT-DNA association. ERK also targets Ser676 but interacts with NFATc4 at a distinct region from RSK.","method":"DNA affinity isolation, in-gel kinase assay, in vitro phosphorylation, mutagenesis, reporter assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 — in vitro kinase assay with site-specific mutagenesis and DNA-binding measurement, single rigorous paper","pmids":["15657420"],"is_preprint":false},{"year":2007,"finding":"RSK2 directly interacts with NFATc4 (via N-terminal aa 1-68 and C-terminal aa 416-674 kinase domains of RSK2 binding to aa 261-365 of NFAT3). Upon calcium ionophore stimulation, RSK2 induces nuclear localization of NFATc4 and phosphorylates NFATc4 in vitro (Km = 3.559 µM). RSK2/NFATc4 signaling drives skeletal muscle cell differentiation into multinucleated myotubes.","method":"Co-immunoprecipitation, in vitro kinase assay, domain mapping, siRNA knockdown, C2C12 differentiation assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro kinase assay, domain-level interaction mapping, functional differentiation phenotype with siRNA validation","pmids":["17213202"],"is_preprint":false},{"year":2008,"finding":"mTOR phosphorylates the gate-keeping residues Ser168/170 of NFATc4, maintaining it in the cytoplasm at rest. ERK5 MAP kinase also mediates rephosphorylation of Ser168/170 and promotes NFATc4 nuclear export; ERK5-mediated phosphorylation primes subsequent phosphorylation by CK1α. Ablation of ERK5 in Erk5−/− cells causes defects in NFATc4 rephosphorylation and nucleocytoplasmic shuttling.","method":"Phospho-specific monoclonal antibody, kinetic phosphorylation analysis, Erk5−/− cell lines, mTOR inhibition (rapamycin), in vitro kinase assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 — phospho-specific antibody combined with genetic Erk5 knockout validation and kinase assays","pmids":["18347059"],"is_preprint":false},{"year":2008,"finding":"GSK-3β promotes NFATc4 ubiquitination through Lys48-linked polyubiquitin chains, decreasing NFATc4 protein levels and transcriptional activity. GSK-3β-induced phosphorylation and ubiquitination represses NFATc4-dependent cardiac gene expression.","method":"Ubiquitination assay, proteasome inhibitor treatment, GSK-3β activation/inhibition, reporter assays, Western blot","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 — direct ubiquitination demonstrated with mechanistic follow-up, single lab","pmids":["19026640"],"is_preprint":false},{"year":2010,"finding":"Lipin 1 represses NFATc4 transcriptional activity through direct protein-protein interaction and is recruited to NFATc4 target gene promoters in vivo. Catalytically active and inactive lipin 1 both suppress NFATc4, and the suppression may involve recruitment of histone deacetylases. Loss of lipin 1 in adipocytes increases expression of NFATc4 targets including TNFα, resistin, FABP4, and PPARγ.","method":"Co-immunoprecipitation, chromatin immunoprecipitation (ChIP), reporter assays, siRNA knockdown, lipin 1-deficient (fld) mouse tissue analysis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP, ChIP, genetic mouse model, multiple orthogonal methods","pmids":["20385772"],"is_preprint":false},{"year":2012,"finding":"NFATc4 and NFATc3 form complexes that are required redundantly for cardiac development; NFATc4 constitutively active form rescues ventricular myocyte proliferation, compact zone density, trabecular formation, and cardiac mitochondrial complex II enzymatic activity in nfatc3−/−nfatc4−/− double-knockout embryos.","method":"Genetic double knockout, cardiac-specific transgenic rescue, mitochondrial enzyme activity assays, electron microscopy","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis with functional rescue, mitochondrial enzymatic readout","pmids":["12750314"],"is_preprint":false},{"year":2005,"finding":"NFATc4 (NFAT3) interacts with estrogen receptor alpha and beta in a ligand-independent manner, binding specifically to the AF-1 domain of ERβ. NFATc4 acts as a co-activator of both ERα and ERβ, enhancing their transcriptional activities and increasing NFAT3 binding of ERα to the estrogen-responsive element.","method":"Yeast two-hybrid, co-immunoprecipitation in mammalian cells, in vitro binding assay, ChIP, reporter assays, siRNA knockdown","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — yeast two-hybrid confirmed by Co-IP and in vitro binding, domain mapping, ChIP, multiple methods","pmids":["16219765"],"is_preprint":false},{"year":2011,"finding":"FoxP1 forms a complex with Nfat3 (NFATc4) in cardiomyocytes, visualized by bimolecular fluorescence complementation (BiFC). Calcineurin activation induces FoxP1-Nfat3 complex formation. FoxP1 represses Nfat3-activated hypertrophy-associated genes (Myh7, Rcan1, Cx43, Anf, Bnp) and activates genes maintaining normal heart function (Myh6, p57Kip2). Co-occupancy of FoxP1 and Nfat3 at hypertrophy gene promoters is demonstrated in vivo.","method":"BiFC, amino acid substitution mutagenesis at interaction interface, ChIP in neonatal and adult heart tissue, reporter assays, cardiomyocyte hypertrophy phenotyping","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — BiFC with mutagenesis validation, ChIP in native tissue, multiple orthogonal methods","pmids":["21606195"],"is_preprint":false},{"year":2007,"finding":"IL-18 induces ERK1/2-dependent phosphorylation of NFATc4 at Ser676, promoting NFATc4 nuclear translocation and in vivo DNA binding to the adiponectin promoter NFAT binding site, thereby suppressing adiponectin transcription in 3T3-L1 adipocytes.","method":"Reporter assay with NFAT site mutation, in vivo DNA binding assay, ERK1/2 inhibitors (U0126, PD98059), ERK1/2 siRNA, NFATc4 siRNA knockdown","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — mechanistic pathway defined with promoter mutagenesis, kinase inhibitors, and two siRNA knockdown targets","pmids":["18086672"],"is_preprint":false},{"year":2004,"finding":"NFATc4 (Nishéd-binding partner) forms a ternary complex with the transcription factor Nishéd and co-activator p300 at an intronic regulatory element (IRE) of the MLC-2v gene. Angiotensin II stimulation enhances this complex formation and MLC-2v transcription; losartan (AT1 antagonist) abolishes it.","method":"Gel mobility shift assay, co-immunoprecipitation, reporter assays, pharmacological antagonism","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2-3 — ternary complex identified by EMSA and Co-IP with functional reporter validation, single lab","pmids":["15272022"],"is_preprint":false},{"year":2009,"finding":"NFATc4 is a transcriptional repressor of GAP-43 in neurons. Prior to neurotrophin activation, endogenous NFATc4 occupies the GAP-43 promoter in PC-12 cells, cultured neurons, and mouse brain. Overexpression of NFATc4 represses GAP-43 activation by neurotrophin signaling, and NFATc4 is required to repress GAP-43 and other pro-axon outgrowth genes during specific developmental windows.","method":"ChIP in vitro and in vivo, reporter assays, overexpression, promoter in silico analysis validated experimentally","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — ChIP in vivo and in vitro, overexpression with functional readout, multiple cellular systems","pmids":["19443652"],"is_preprint":false},{"year":2009,"finding":"NFATc4 knockdown induces apoptosis in cortical neurons even under survival conditions. NFATc4 mediates NMDAR-dependent neuronal survival by regulating transcription from BDNF promoter IV; NFATc4 inhibition reduces BDNF expression, and exogenous BDNF rescues the pro-apoptotic effects of NFATc4 inhibition.","method":"RNAi knockdown, dominant-negative NFAT expression, reporter assays with BDNF promoter IV, neuronal apoptosis assays","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — loss-of-function with defined molecular pathway, rescue experiment, multiple neuronal models","pmids":["19955386"],"is_preprint":false},{"year":2012,"finding":"NFATc4 calcineurin-dependent activity is specifically required for survival of adult-born hippocampal neurons in response to BDNF signaling. Cyclosporin A injection or TrkB-Fc (BDNF scavenger) reduces adult-born neuron survival in WT but not NFATc4−/− mice. Loss of NFATc4 leads to selective defects in LTP and spatial memory encoding.","method":"NFATc4 knockout mice, stereotaxic drug delivery, calcineurin inhibition, TrkB-Fc scavenger, hippocampal neurogenesis quantification, LTP electrophysiology, spatial memory behavioral testing","journal":"Proceedings of the National Academy of Sciences","confidence":"High","confidence_rationale":"Tier 2 — genetic knockout with multiple orthogonal functional readouts (survival, LTP, behavior), BDNF pathway placed upstream","pmids":["22586092"],"is_preprint":false},{"year":2012,"finding":"NFATc4 activation properties in neurons differ from NFATc3: NFATc4 requires prolonged (1-3 h) depolarization for nuclear translocation whereas NFATc3 translocates rapidly. The serine-proline repeat region of NFATc4 is critical for its activation magnitude. GSK3β suppression is specifically required for NFATc4 nuclear import upon depolarization.","method":"NFATc3/NFATc4 chimera analysis, siRNA knockdown, GSK3β inhibition, live imaging of nuclear translocation in hippocampal and DRG neurons, p38 and mTOR inhibition","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — domain chimeras with live imaging, genetic knockdown, pharmacological dissection of multiple kinases","pmids":["22977251"],"is_preprint":false},{"year":2013,"finding":"NFAT3 directly binds to specific DNA sequences within the BACE1 promoter and activates BACE1 transcription; NFATc4 overexpression increases BACE1 promoter activity, BACE1 protein expression, and Aβ production.","method":"ChIP, luciferase reporter assays, overexpression, siRNA knockdown","journal":"Neurochemical research","confidence":"Medium","confidence_rationale":"Tier 2-3 — ChIP with reporter validation, single lab","pmids":["25663301"],"is_preprint":false},{"year":2013,"finding":"NFAT3 directly regulates miR-140 transcription in OA chondrocytes by binding to the miR-140 regulatory sequence, acting as a transcriptional activator. TGF-β/SMAD3 acts as a repressor. TGF-β interferes with NFAT3 translocation, thereby suppressing miR-140 expression. These roles were established by mutagenesis, ChIP, and siRNA knockdown.","method":"ChIP, promoter mutagenesis, siRNA knockdown, immunocytochemistry, reporter assays","journal":"Arthritis research & therapy","confidence":"High","confidence_rationale":"Tier 2 — ChIP with mutagenesis validation, siRNA knockdown, multiple methods in single study","pmids":["24257415"],"is_preprint":false},{"year":2014,"finding":"NFATc4 drives hippocampal progenitor neurogenesis via the calcineurin/NFATc4 axis. NFATc4 directly regulates GABRA2 and GABRA4 subunit expression by binding to specific promoter responsive elements. GABAAR signaling promotes neurogenesis through NFATc4, and NFATc4-dependent increase in neurogenesis is required for suppression of anxiety response.","method":"Genome-wide ChIP, luciferase reporter assays, calcineurin inhibition (cyclosporin A), NFATc4−/− mice, behavioral anxiety testing, pharmacological GABAAR modulation","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — genome-wide ChIP with promoter validation, genetic knockout, behavioral readout","pmids":["24948817"],"is_preprint":false},{"year":2016,"finding":"CDK3 directly interacts with NFATc4 (by mammalian two-hybrid assay) and phosphorylates NFATc4 at Ser259, enhancing its transactivation activity. Mutation of Ser259 to Ala reduces NFATc4-dependent colony formation and xenograft tumor growth.","method":"Mammalian two-hybrid assay, in vitro phosphorylation/kinase assay, site-directed mutagenesis (S259A), soft agar colony formation, xenograft mouse model","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro phosphorylation, mutagenesis validated in vitro and in vivo, two-hybrid interaction","pmids":["27893713"],"is_preprint":false},{"year":2016,"finding":"NFATc4 is recruited to the Kv4.2 gene promoter and is required for neuritin-induced Kv4.2 transcriptional upregulation. The Ca2+/calcineurin/NFATc4 axis mediates neuritin-induced potentiation of IA densities in cerebellar granule neurons; these effects are absent in Nfatc4−/− but not Nfatc2−/− mice.","method":"ChIP, luciferase reporter assays, calcineurin inhibition, Nfatc4−/− mice, electrophysiology, AAV-mediated neuritin overexpression","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — ChIP with reporter validation, genetic knockout with isoform specificity, functional electrophysiology","pmids":["27307045"],"is_preprint":false},{"year":2018,"finding":"BDNF sequesters NFATc4 in extranuclear Golgi compartments, thereby derepressing an NFI-dependent temporal gene program in cerebellar granule cells. This extranuclear sequestration reveals an autoregulatory loop as Bdnf itself is part of the NFI target program.","method":"Subcellular fractionation/localization, Golgi co-localization, gene expression analysis, NFATc4 loss-of-function","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2-3 — novel localization mechanism with functional gene expression consequence, single lab","pmids":["29467254"],"is_preprint":false},{"year":2019,"finding":"SIRT6, via its deacetylase activity, suppresses NFATc4 expression and activation in cardiomyocytes; SIRT6 interacts with NFATc4, likely facilitating its deacetylation. SIRT6 overexpression elevates NFATc4 phosphorylation, prevents nuclear accumulation, and suppresses transcriptional activity, while deacetylase-dead SIRT6 (H133Y mutant) has no effect.","method":"Co-immunoprecipitation, adenoviral overexpression, deacetylase-dead mutant (H133Y), Western blot, immunofluorescence, siRNA knockdown, reporter assays","journal":"Frontiers in pharmacology","confidence":"Medium","confidence_rationale":"Tier 2-3 — Co-IP with deacetylase-dead mutant control, functional hypertrophy readout, single lab","pmids":["30670969"],"is_preprint":false},{"year":2019,"finding":"RCAN1.4 overexpression alleviates liver fibrosis through inhibition of calcineurin/NFAT3 (NFATc4) signaling. Downregulation of RCAN1.4 by DNMT1- and DNMT3b-mediated DNA methylation of its promoter relieves inhibition of calcineurin, activating NFATc4 and promoting HSC activation and fibrogenesis.","method":"Bisulfite sequencing PCR, ChIP for DNMT1/DNMT3b, rAAV8-mediated RCAN1.4 overexpression, CaN activity assays, siRNA knockdown, CCl4 mouse fibrosis model","journal":"Theranostics","confidence":"High","confidence_rationale":"Tier 2 — mechanistic pathway defined with ChIP for methyltransferases, genetic overexpression in vivo, multiple orthogonal methods","pmids":["31285763"],"is_preprint":false},{"year":2020,"finding":"NFATc4 directly binds to PPARα in the nucleus and negatively regulates its transcriptional activity, impairing hepatic fatty acid oxidation and increasing lipid deposition in NASH. NFATc4 activation also increases osteopontin (OPN) secretion from hepatocytes, driving macrophage-mediated inflammation and hepatic stellate cell fibrosis via paracrine signaling.","method":"NFATc4 knockdown (gain/loss of function), co-immunoprecipitation (NFATc4-PPARα), reporter assays, OPN secretion measurement, paracrine co-culture experiments, NASH mouse model","journal":"Journal of hepatology","confidence":"High","confidence_rationale":"Tier 2 — Co-IP of direct protein interaction, genetic knockdown with defined molecular mechanism, in vivo model","pmids":["32717288"],"is_preprint":false},{"year":2020,"finding":"NULP1 directly interacts with NFATc4 via its topologically associating domain (TAD) through the C-terminal region of NULP1, suppressing NFATc4 transcriptional activity. NULP1 knockout exacerbates cardiac hypertrophy, rescued by NFAT pathway inhibition with VIVIT peptides.","method":"Co-immunoprecipitation (domain mapping), NULP1 knockout/transgenic mice, VIVIT peptide treatment, aortic banding model, reporter assays","journal":"Journal of the American Heart Association","confidence":"High","confidence_rationale":"Tier 2 — Co-IP with domain mapping, genetic knockout with pharmacological rescue, in vivo model","pmids":["32805187"],"is_preprint":false},{"year":2020,"finding":"NFATc4 nuclear translocation and pathway activation drives quiescence (G0 arrest) and chemotherapy resistance in ovarian cancer cells, in part via downregulation of MYC. Cisplatin treatment triggers NFATc4 nuclear translocation; inhibition of NFATc4 increases chemotherapy response both in vitro and in vivo.","method":"NFATc4 overexpression/inhibition, flow cytometry for cell cycle, cisplatin response assays, in vivo xenograft, MYC expression analysis","journal":"JCI insight","confidence":"Medium","confidence_rationale":"Tier 2-3 — functional loss/gain-of-function with mechanistic link to MYC, validated in vivo, single lab","pmids":["32182216"],"is_preprint":false},{"year":2021,"finding":"SIRT2-mediated deacetylation of NFATc4 inhibits its nuclear translocation. In ethanol-exposed hepatocytes, PTS (pterostilbene) rescues SIRT2 expression, which deacetylates NFATc4 and prevents its nuclear translocation; NFATc4 overexpression impairs the ability of PTS to suppress RIPK3 expression and necroptosis.","method":"NFATc4 overexpression/knockdown, SIRT2 siRNA knockdown, immunofluorescence for NFATc4 nuclear localization, Western blot for acetylation status, RIPK3 expression","journal":"Toxicology","confidence":"Medium","confidence_rationale":"Tier 3 — indirect deacetylation evidence via pathway inhibition, single lab, mechanistic follow-up incomplete","pmids":["34474091"],"is_preprint":false},{"year":2021,"finding":"NFATc4 triggers hepatocyte senescence via repression of PPARγ in ethanol-treated hepatocytes. NFATc4 knockdown protected against ethanol-induced senescence markers (SA-β-gal, p16, p21, HMGA1, γH2AX), and PPARγ deficiency abrogated these protective effects.","method":"NFATc4 siRNA knockdown, PPARγ knockdown, SA-β-gal staining, Western blot for senescence markers, in vivo mouse alcoholic liver model","journal":"Toxicology letters","confidence":"Medium","confidence_rationale":"Tier 2-3 — epistasis through double knockdown, in vivo validation, single lab","pmids":["34192554"],"is_preprint":false},{"year":2022,"finding":"PPP3CA (calcineurin catalytic subunit) and CAMTA1 competitively bind to NFATc4; CAMTA1 knockdown promotes PPP3CA-mediated dephosphorylation of NFATc4, activating it and promoting colorectal cancer chemoresistance. NFATc4 knockdown reverses chemoresistance caused by CAMTA1 knockdown.","method":"Co-immunoprecipitation, NFATc4 knockdown, CAMTA1 overexpression/knockdown, xenograft mouse model, oxaliplatin resistance assays","journal":"Cell death discovery","confidence":"Medium","confidence_rationale":"Tier 2-3 — competitive Co-IP with functional epistasis, in vivo xenograft validation","pmids":["35332122"],"is_preprint":false},{"year":2023,"finding":"Calcineurin (protein phosphatase 3) dephosphorylates NFATc4 in adrenal zona glomerulosa cells. Phosphoproteomics identified NFATc4 as a calcineurin substrate. ZG-specific deletion of the calcineurin regulatory subunit CnB1 reduces Cyp11b2 expression. NFATc4 directly binds the CYP11B2 (aldosterone synthase) promoter via ChIP, and constitutively active NFATc4 increases CYP11B2 expression; NFATc4 deletion impairs K+-dependent aldosterone synthesis.","method":"Phosphoproteomics, ZG-specific CnB1 knockout mice, NFATc4 knockout, constitutively active NFATc4 expression, ChIP for CYP11B2 promoter, aldosterone secretion assays","journal":"JCI insight","confidence":"High","confidence_rationale":"Tier 1-2 — phosphoproteomics identifies substrate, ChIP confirms direct promoter binding, two genetic models validate the pathway","pmids":["37310791"],"is_preprint":false},{"year":2024,"finding":"Mettl1-catalyzed m7G modification of SRSF9 mRNA increases SRSF9 expression, which then promotes alternative splicing and stabilization of NFATc4, thereby activating cardiac hypertrophy. SRSF9 knockdown protects against TAC- or Mettl1-induced cardiac hypertrophy. YY1 acts as a transcription factor for Mettl1 during cardiac hypertrophy.","method":"Mettl1 knockout/overexpression, SRSF9 knockdown, alternative splicing analysis, TAC and Ang II mouse models, m7G modification profiling","journal":"Advanced science","confidence":"Medium","confidence_rationale":"Tier 2 — genetic loss/gain-of-function in vivo with mechanistic link to mRNA splicing/stability, single recent study","pmids":["38810124"],"is_preprint":false},{"year":2011,"finding":"PPARα activation by fenofibrate enhances association of PPARα with NFATc4 in the nucleus, competing with and decreasing NFATc4 interaction with GATA-4, thereby reducing transactivation of the BNP gene and inhibiting cardiomyocyte hypertrophy.","method":"EMSA, co-immunoprecipitation, PPARα siRNA knockdown, reporter assays, confocal microscopy, primary neonatal rat cardiomyocytes","journal":"Archives of biochemistry and biophysics","confidence":"Medium","confidence_rationale":"Tier 2 — EMSA and Co-IP with siRNA validation, multiple methods in single lab","pmids":["22198280"],"is_preprint":false},{"year":2016,"finding":"NFATc4 interacts with myocardin to synergistically activate LTCC α1C (L-type Ca2+ channel) gene expression in ET-1-induced cardiomyocyte hypertrophy. NFATc4 also directly activates myocardin expression by binding to its promoter.","method":"Co-immunoprecipitation, ChIP, reporter assays, NFATc4 and myocardin overexpression/knockdown","journal":"Life sciences","confidence":"Medium","confidence_rationale":"Tier 2-3 — Co-IP and ChIP in same study, single lab","pmids":["27155398"],"is_preprint":false},{"year":2017,"finding":"TBX5 transcription factor binds to the NFAT3 promoter and is required for NFAT3 expression; mutation of the TBX5 binding site in the NFAT3 promoter diminishes promoter activity, while TBX5 overexpression enhances NFAT3 expression. TBX5-mediated NFAT3 expression suppresses IL-2 transcription, establishing TBX5 as a transcriptional regulator of NFAT3 in T cells. NFAT3 suppresses IL-2 promoter activity through its N-terminal transactivation domain, Ca2+-regulatory domain, and DNA-binding domain.","method":"Promoter mutagenesis, reporter assays, TBX5 overexpression in CD4+ T cells, siRNA knockdown, chromatin accessibility analysis","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 — promoter mutagenesis with functional rescue, domain mapping using chimeras, single lab","pmids":["29180489"],"is_preprint":false},{"year":2019,"finding":"Orai1-dependent Ca2+ entry activates calcineurin-NFATc4 signaling specifically in endothelial cells; among all NFAT isoforms, TNFα exclusively triggers NFATc4 nuclear accumulation in HUVECs. Orai1 knockdown prevents TNFα-induced NFATc4 nuclear translocation and reduces ICAM-1 and VCAM-1 expression.","method":"Orai1 knockdown/overexpression, NFATc4 overexpression, calcineurin inhibition, nuclear translocation imaging, ICAM-1/VCAM-1 expression, in vivo mouse aorta","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2-3 — isoform-specific nuclear translocation validated with multiple tools, in vivo confirmation","pmids":["29225169"],"is_preprint":false},{"year":2019,"finding":"NFATc4 deficiency in cochlear hair cells attenuates ototoxic drug-induced apoptosis. NFATc4 is activated and translocates from cytoplasm to nucleus in response to ototoxic drugs, followed by increased Tnf expression and downstream apoptosis pathway activation. Nfatc4-deficient hair cells show reduced TNF-mediated apoptosis.","method":"Nfatc4−/− mice, ototoxic drug treatment, immunofluorescence for NFATc4 localization, Western blot for Tnf and downstream apoptosis markers, hearing function tests","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 2 — genetic knockout with defined NFATc4-Tnf-apoptosis pathway, functional hearing readout","pmids":["31379853"],"is_preprint":false},{"year":2024,"finding":"NFATc4 knockout (but not NFATc3 knockout) increases retinal ganglion cell (RGC) survival, improves retinal function, and delays axonal degeneration after optic nerve crush. NFATc4 up-regulation after injury immunolocalizes to the ganglion cell layer. Lentiviral re-introduction of NFATc4 into NFATc4−/− retinas reverses the pro-survival effect, confirming NFATc4-dependent pro-apoptotic signaling (involving caspase-3).","method":"NFATc4−/− and NFATc3−/− mice, optic nerve crush model, lentiviral NFATc4 delivery, microarray, immunostaining for cleaved caspase-3, retinal function assessment","journal":"Molecular neurobiology","confidence":"High","confidence_rationale":"Tier 2 — genetic knockout with isoform specificity confirmed by rescue experiment, multiple functional readouts","pmids":["38639863"],"is_preprint":false},{"year":2010,"finding":"miR-133a directly targets two conserved base-pairing sites in the NFATc4 3'-UTR, negatively regulating NFATc4 expression. Mutation of both sites in the NFATc4 3'-UTR completely blocks miR-133a-mediated repression. miR-133a reduces endogenous NFATc4 protein and attenuates hypertrophic stimulus-induced NFATc4 upregulation.","method":"Luciferase reporter with 3'-UTR, 3'-UTR site-directed mutagenesis, miR-133a gain-of-function, miR-133a inhibitor treatment, Western blot","journal":"American journal of physiology. Heart and circulatory physiology","confidence":"High","confidence_rationale":"Tier 2 — 3'-UTR mutagenesis confirms direct targeting, gain- and loss-of-function both performed","pmids":["20173049"],"is_preprint":false}],"current_model":"NFATc4 is a calcium-regulated transcription factor that resides in the cytoplasm in a hyperphosphorylated, inactive state; upon elevation of intracellular Ca2+, calcineurin dephosphorylates NFATc4 (including key gate-keeping residues Ser168/170), driving its nuclear translocation where it activates or represses target genes (including Kv4.2, GABRA2/4, BNP, GAP-43, CYP11B2, BACE1, PPARγ2, LTCC α1C, and FasL) by interacting with co-factors such as CBP (via dual transactivation domain contacts), GATA-4, myocardin, FoxP1, PPARα, lipin 1, NULP1, and estrogen receptors; multiple kinases (GSK-3, p38, mTOR, ERK5, ERK1/2/RSK, CDK3) rephosphorylate NFATc4 to promote its nuclear export or ubiquitin-proteasome-mediated degradation, while post-translational modifications including SIRT2/SIRT6-mediated deacetylation and Mettl1/SRSF9-regulated alternative splicing further modulate its activity, enabling NFATc4 to function as a context-dependent regulator of cardiac hypertrophy, neuronal survival/apoptosis, adult hippocampal neurogenesis, aldosterone synthesis, and metabolic liver disease."},"narrative":{"teleology":[{"year":1999,"claim":"Established that NFATc4 is a calcium/calcineurin-dependent transcription factor in neurons, resolving how electrical activity is coupled to nuclear gene regulation: L-type calcium channel entry triggers calcineurin-dependent nuclear translocation, while GSK-3 opposes this by phosphorylating NFATc4 to promote export.","evidence":"Live imaging of NFATc4-GFP in hippocampal neurons with pharmacological inhibition of L-type channels, calcineurin inhibitors, and GSK-3 kinase assays","pmids":["10537109"],"confidence":"High","gaps":["Identity of the specific GSK-3 phosphorylation sites on NFATc4 not mapped","Downstream neuronal target gene program not characterized genome-wide"]},{"year":2001,"claim":"Defined how NFATc4 engages transcriptional coactivators: dual transactivation domains (N- and C-terminal) contact distinct regions of CBP (KIX and CH3 domains), and both contacts are required for transcriptional potentiation.","evidence":"Co-immunoprecipitation with deletion mutagenesis and reporter gene assays","pmids":["11514544"],"confidence":"High","gaps":["Structural basis of dual-domain CBP engagement unknown","Whether other NFAT family members share this bipartite mechanism not tested"]},{"year":2002,"claim":"Identified Ser168/170 as critical gate-keeping phosphorylation sites: p38 MAPK phosphorylates these residues to enforce cytoplasmic retention, and their mutation to alanine constitutively activates NFATc4, driving PPARγ2 expression and adipocyte differentiation.","evidence":"In vitro kinase assay, site-directed mutagenesis, adipocyte differentiation assays","pmids":["11997522"],"confidence":"High","gaps":["Whether p38 is the dominant kinase at Ser168/170 in all tissues not resolved"]},{"year":2005,"claim":"Revealed that ERK/RSK signaling potentiates NFATc4 activity by phosphorylating Ser676, which enhances DNA binding rather than promoting export—establishing a pro-activating kinase input distinct from the export-promoting kinases.","evidence":"DNA affinity isolation, in-gel kinase assay, Ser676 mutagenesis, reporter assays","pmids":["15657420"],"confidence":"High","gaps":["How Ser676 phosphorylation structurally enhances DNA binding is unknown","Relative contributions of ERK versus RSK at Ser676 in vivo not quantified"]},{"year":2005,"claim":"Expanded NFATc4's cofactor repertoire beyond CBP: NFATc4 interacts with estrogen receptors α and β in a ligand-independent manner, functioning as a coactivator of ER-dependent transcription.","evidence":"Yeast two-hybrid confirmed by Co-IP, in vitro binding, ChIP, and reporter assays","pmids":["16219765"],"confidence":"High","gaps":["ER–NFATc4 target genes in physiological contexts not identified","In vivo relevance in estrogen-responsive tissues not demonstrated"]},{"year":2007,"claim":"RSK2 was identified as a direct NFATc4 interactor with defined binding domains, showing that RSK2-mediated phosphorylation promotes nuclear localization and drives skeletal muscle differentiation.","evidence":"Co-IP with domain mapping, in vitro kinase assay (Km determined), siRNA knockdown, C2C12 myotube differentiation","pmids":["17213202"],"confidence":"High","gaps":["Whether RSK2 phosphorylates the same Ser676 or additional sites not fully resolved"]},{"year":2008,"claim":"Delineated the rephosphorylation cascade at Ser168/170: mTOR maintains basal phosphorylation, while ERK5 rephosphorylates these sites after calcineurin-driven dephosphorylation and primes CK1α-mediated sequential phosphorylation to enforce nuclear export.","evidence":"Phospho-specific antibody, Erk5−/− cells, rapamycin inhibition, in vitro kinase assays","pmids":["18347059"],"confidence":"High","gaps":["Whether additional kinases contribute to Ser168/170 rephosphorylation in specific tissues"]},{"year":2008,"claim":"Established that GSK-3β not only promotes NFATc4 nuclear export but also targets it for K48-linked polyubiquitination and proteasomal degradation, adding protein turnover as a regulatory layer.","evidence":"Ubiquitination assays with proteasome inhibitors, GSK-3β activation/inhibition, reporter assays","pmids":["19026640"],"confidence":"Medium","gaps":["The E3 ubiquitin ligase mediating GSK-3β-triggered NFATc4 degradation is unidentified","Ubiquitination sites on NFATc4 not mapped"]},{"year":2009,"claim":"Demonstrated that NFATc4 functions as a transcriptional repressor at the GAP-43 promoter in neurons and as a survival factor via BDNF promoter IV activation—establishing its dual activator/repressor function depending on target gene context.","evidence":"ChIP in PC-12 cells, cultured neurons, and mouse brain for GAP-43; RNAi knockdown with BDNF rescue for neuronal survival","pmids":["19443652","19955386"],"confidence":"High","gaps":["Mechanism by which NFATc4 switches between activation and repression at different promoters is unknown"]},{"year":2010,"claim":"miR-133a was identified as a direct post-transcriptional repressor of NFATc4 via two conserved sites in its 3′-UTR, providing a microRNA-based mechanism that limits NFATc4 protein levels during cardiac hypertrophy.","evidence":"3′-UTR luciferase reporter with site-directed mutagenesis, miR-133a gain- and loss-of-function","pmids":["20173049"],"confidence":"High","gaps":["Whether other miRNAs cooperatively regulate NFATc4 not explored","In vivo cardiac hypertrophy rescue by miR-133a-mediated NFATc4 suppression not tested"]},{"year":2010,"claim":"Lipin 1 was identified as a direct nuclear repressor of NFATc4 transcriptional activity via protein–protein interaction at target gene promoters, revealing a metabolic enzyme as a transcriptional corepressor of NFATc4 in adipocytes.","evidence":"Co-IP, ChIP at target promoters, siRNA knockdown, fld (lipin 1-deficient) mouse tissue","pmids":["20385772"],"confidence":"High","gaps":["Whether lipin 1 enzymatic activity contributes independently from its scaffold function remains debated"]},{"year":2011,"claim":"FoxP1 was shown to form a calcineurin-dependent complex with NFATc4 at hypertrophy gene promoters in cardiomyocytes, functioning as a repressive partner that redirects NFATc4 from hypertrophic to homeostatic gene programs.","evidence":"BiFC visualization, mutagenesis at interaction interface, ChIP in neonatal and adult heart tissue","pmids":["21606195"],"confidence":"High","gaps":["How the FoxP1–NFATc4 complex discriminates between hypertrophic and homeostatic promoters"]},{"year":2011,"claim":"PPARα was found to compete with GATA-4 for NFATc4 binding in cardiomyocytes, suppressing BNP transactivation and hypertrophy—revealing cofactor competition as a mechanism for modulating NFATc4 output.","evidence":"EMSA, Co-IP, PPARα siRNA knockdown, reporter assays in neonatal rat cardiomyocytes","pmids":["22198280"],"confidence":"Medium","gaps":["Structural basis for PPARα–NFATc4 versus GATA-4–NFATc4 competition is unknown","In vivo confirmation in cardiac tissue not provided"]},{"year":2012,"claim":"NFATc4 was established as essential for adult hippocampal neurogenesis and spatial memory: BDNF/TrkB-calcineurin-NFATc4 signaling selectively supports survival of adult-born neurons, and NFATc4 knockout impairs LTP and memory.","evidence":"NFATc4−/− mice, stereotaxic cyclosporin A and TrkB-Fc delivery, hippocampal neurogenesis quantification, LTP electrophysiology, behavioral spatial memory testing","pmids":["22586092"],"confidence":"High","gaps":["Downstream transcriptional targets mediating NFATc4-dependent neuronal survival in the adult hippocampus not fully defined"]},{"year":2012,"claim":"Clarified isoform-specific activation kinetics: NFATc4 requires prolonged depolarization (1–3 h) for nuclear translocation (unlike rapid NFATc3), the serine-proline repeat region determines activation magnitude, and GSK-3β suppression is specifically required for NFATc4 nuclear import.","evidence":"NFATc3/c4 chimera analysis, live imaging, GSK-3β inhibition, siRNA in hippocampal and DRG neurons","pmids":["22977251"],"confidence":"High","gaps":["Structural basis for how the serine-proline repeat tunes activation threshold is unknown"]},{"year":2012,"claim":"NFATc3 and NFATc4 were shown to be redundantly required for cardiac development; double knockout is lethal with defects in myocyte proliferation, trabeculation, and mitochondrial complex II activity, all rescued by constitutively active NFATc4.","evidence":"Genetic double knockout, cardiac-specific transgenic rescue, mitochondrial enzyme assays, electron microscopy","pmids":["12750314"],"confidence":"High","gaps":["Direct transcriptional targets mediating mitochondrial complex II regulation not identified"]},{"year":2014,"claim":"Genome-wide ChIP identified GABRA2 and GABRA4 as direct NFATc4 target genes in hippocampal progenitors, linking GABA receptor signaling to calcineurin-NFATc4-dependent adult neurogenesis and anxiety-related behavior.","evidence":"Genome-wide ChIP, luciferase reporters, NFATc4−/− mice, behavioral anxiety tests, pharmacological GABAAR modulation","pmids":["24948817"],"confidence":"High","gaps":["Full set of NFATc4 direct targets in hippocampal progenitors beyond GABRA genes not catalogued"]},{"year":2016,"claim":"CDK3 was identified as a direct NFATc4 kinase at Ser259 that enhances transactivation and promotes cell transformation, expanding NFATc4 regulation to cell cycle kinases and oncogenic contexts.","evidence":"Mammalian two-hybrid, in vitro kinase assay, S259A mutagenesis, colony formation, xenograft model","pmids":["27893713"],"confidence":"High","gaps":["Whether CDK3-NFATc4 axis is active in non-transformed cells not established"]},{"year":2016,"claim":"NFATc4 was shown to be specifically required (not NFATc2) for neuritin-induced Kv4.2 channel transcription in cerebellar granule neurons, establishing isoform-specific transcriptional control of neuronal excitability.","evidence":"ChIP at Kv4.2 promoter, Nfatc4−/− versus Nfatc2−/− mice, electrophysiology, AAV-neuritin","pmids":["27307045"],"confidence":"High","gaps":["Broader ion channel gene program regulated by NFATc4 in cerebellum not mapped"]},{"year":2018,"claim":"BDNF was found to sequester NFATc4 in Golgi compartments rather than the nucleus, derepressing an NFI-dependent gene program—revealing a non-canonical extranuclear mechanism of NFATc4 regulation.","evidence":"Subcellular fractionation, Golgi co-localization, gene expression analysis in cerebellar granule cells","pmids":["29467254"],"confidence":"Medium","gaps":["Mechanism of Golgi retention is unknown","Generalizability beyond cerebellar granule cells not tested"]},{"year":2019,"claim":"SIRT6 deacetylase activity was shown to suppress NFATc4 nuclear accumulation and transcriptional activity in cardiomyocytes, adding lysine acetylation as a regulatory modification controlling NFATc4 localization.","evidence":"Co-IP, deacetylase-dead H133Y mutant, adenoviral overexpression, siRNA knockdown, reporter assays","pmids":["30670969"],"confidence":"Medium","gaps":["Specific acetylated lysine residues on NFATc4 not identified","Whether SIRT6 directly deacetylates NFATc4 or acts indirectly not definitively resolved"]},{"year":2019,"claim":"NFATc4 deficiency protects cochlear hair cells from ototoxic drug-induced apoptosis via reduced TNF expression, establishing NFATc4 as a pro-apoptotic transcription factor in sensory cells.","evidence":"Nfatc4−/− mice, ototoxic drug treatment, immunofluorescence, hearing function tests","pmids":["31379853"],"confidence":"Medium","gaps":["Direct binding of NFATc4 to the Tnf promoter in hair cells not demonstrated by ChIP"]},{"year":2020,"claim":"NFATc4 was established as a driver of NASH pathogenesis through dual mechanisms: direct binding to and inhibition of PPARα transcriptional activity (impairing fatty acid oxidation) and osteopontin-mediated paracrine activation of macrophages and stellate cells.","evidence":"Co-IP of NFATc4–PPARα, OPN secretion assays, paracrine co-culture, NASH mouse model","pmids":["32717288"],"confidence":"High","gaps":["NFATc4 target genes beyond PPARα and OPN in hepatocytes not catalogued"]},{"year":2020,"claim":"NULP1 was identified as a direct NFATc4-interacting repressor whose loss exacerbates cardiac hypertrophy—rescued by NFAT pathway inhibition—adding another nuclear cofactor that restrains NFATc4 output.","evidence":"Co-IP with domain mapping, NULP1 knockout/transgenic mice, VIVIT peptide rescue, aortic banding model","pmids":["32805187"],"confidence":"High","gaps":["Mechanism by which NULP1 inhibits NFATc4 transactivation not resolved"]},{"year":2021,"claim":"SIRT2-mediated deacetylation was shown to inhibit NFATc4 nuclear translocation in hepatocytes, and NFATc4 represses PPARγ to drive ethanol-induced hepatocyte senescence, linking NFATc4 to alcoholic liver disease.","evidence":"SIRT2 siRNA, NFATc4 overexpression/knockdown, PPARγ epistasis, senescence markers, alcoholic liver mouse model","pmids":["34474091","34192554"],"confidence":"Medium","gaps":["Direct deacetylation of NFATc4 by SIRT2 not confirmed by in vitro deacetylation assay","NFATc4 acetylation sites remain unmapped"]},{"year":2023,"claim":"Phosphoproteomics identified NFATc4 as a calcineurin substrate in adrenal zona glomerulosa cells; NFATc4 directly binds the CYP11B2 promoter and is required for potassium-stimulated aldosterone synthesis, establishing a new physiological role in mineralocorticoid regulation.","evidence":"Phosphoproteomics, ZG-specific CnB1 knockout, NFATc4 knockout, ChIP at CYP11B2 promoter, aldosterone secretion assays","pmids":["37310791"],"confidence":"High","gaps":["Whether NFATc4 cooperates with other transcription factors at CYP11B2 not defined","Contribution of NFATc4 to primary aldosteronism not tested"]},{"year":2024,"claim":"Mettl1-catalyzed m7G modification of SRSF9 mRNA was shown to increase SRSF9, which promotes alternative splicing and stabilization of NFATc4 transcript, activating cardiac hypertrophy—revealing an epitranscriptomic input to NFATc4 regulation.","evidence":"Mettl1 knockout/overexpression, SRSF9 knockdown, alternative splicing analysis, TAC and Ang II mouse models","pmids":["38810124"],"confidence":"Medium","gaps":["Specific NFATc4 splice variants generated by SRSF9 not characterized","Whether this mechanism operates outside the heart is unknown"]},{"year":2024,"claim":"NFATc4 (but not NFATc3) knockout was shown to promote retinal ganglion cell survival and delay axonal degeneration after optic nerve crush, with lentiviral re-introduction reversing the protective effect—confirming isoform-specific pro-apoptotic function in the retina via caspase-3.","evidence":"NFATc4−/− and NFATc3−/− mice, optic nerve crush, lentiviral rescue, microarray, caspase-3 immunostaining","pmids":["38639863"],"confidence":"High","gaps":["Direct transcriptional targets of NFATc4 driving RGC apoptosis not identified","Whether NFATc4 inhibition is therapeutically viable for glaucoma not tested"]},{"year":null,"claim":"Major unresolved questions include: the identity of the E3 ubiquitin ligase(s) targeting NFATc4, the specific lysine residues subject to acetylation/deacetylation, the structural basis for cofactor selectivity (activator vs. repressor), and the complete genome-wide target gene repertoire across tissues.","evidence":"","pmids":[],"confidence":"Low","gaps":["E3 ligase for NFATc4 ubiquitination unknown","Acetylation sites unmapped","No structural model of NFATc4 with any cofactor","Comprehensive tissue-specific cistrome lacking"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1,2,7,9,10,13,14,17,18,19,21,25,31,34,35]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[3,13,17,18,19,21,31]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,1,3,5,9,10,16,25,27]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,1,5,16]},{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[22]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,3,5,6,11,20,36]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[2,7,9,10,13,14,17,18,19,21,25,31,34,35]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[14,37,38]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[8]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[0,15,16,19,21]}],"complexes":[],"partners":["CBP","GATA4","FOXP1","PPP3CA","GSK3B","PPARA","LPIN1","ESR1"],"other_free_text":[]},"mechanistic_narrative":"NFATc4 is a calcium/calcineurin-regulated transcription factor that integrates diverse extracellular signals to control gene expression programs in the heart, brain, immune cells, adipocytes, and liver. In resting cells, NFATc4 is maintained in the cytoplasm by phosphorylation at gate-keeping residues Ser168/170 by kinases including p38, mTOR, ERK5, and GSK-3β; calcium influx through L-type channels or store-operated Orai1 channels activates calcineurin, which dephosphorylates NFATc4 to drive its nuclear translocation, where it activates or represses target genes (including BDNF, Kv4.2, GABRA2/4, CYP11B2, BACE1, PPARγ2, BNP, and GAP-43) through cooperation with cofactors such as CBP, GATA-4, FoxP1, myocardin, and estrogen receptors [PMID:10537109, PMID:11997522, PMID:18347059, PMID:11514544, PMID:21606195]. Nuclear export and degradation are enforced by rephosphorylation cascades (GSK-3β/ERK5/CK1α priming, RSK/ERK1/2 at Ser676, CDK3 at Ser259) and by GSK-3β-triggered K48-linked polyubiquitination, while SIRT2- and SIRT6-mediated deacetylation and Mettl1/SRSF9-dependent alternative splicing provide additional regulatory layers [PMID:19026640, PMID:15657420, PMID:27893713, PMID:30670969, PMID:38810124]. NFATc4 functions as a context-dependent survival or apoptotic effector—promoting BDNF-dependent adult hippocampal neurogenesis and spatial memory, yet driving caspase-3-dependent apoptosis in retinal ganglion cells and cochlear hair cells after injury—and is required redundantly with NFATc3 for cardiac development [PMID:22586092, PMID:38639863, PMID:31379853, PMID:12750314]."},"prefetch_data":{"uniprot":{"accession":"Q14934","full_name":"Nuclear factor of activated T-cells, cytoplasmic 4","aliases":["T-cell transcription factor NFAT3","NF-AT3"],"length_aa":902,"mass_kda":95.4,"function":"Ca(2+)-regulated transcription factor that is involved in several processes, including the development and function of the immune, cardiovascular, musculoskeletal, and nervous systems (PubMed:11514544, PubMed:11997522, PubMed:17213202, PubMed:17875713, PubMed:18668201, PubMed:25663301, PubMed:7749981). Involved in T-cell activation, stimulating the transcription of cytokine genes, including that of IL2 and IL4 (PubMed:18347059, PubMed:18668201, PubMed:7749981). Along with NFATC3, involved in embryonic heart development. Following JAK/STAT signaling activation and as part of a complex with NFATC3 and STAT3, binds to the alpha-beta E4 promoter region of CRYAB and activates transcription in cardiomyocytes (By similarity). Involved in mitochondrial energy metabolism required for cardiac morphogenesis and function (By similarity). Transactivates many genes involved in the cardiovascular system, including AGTR2, NPPB/BNP (in synergy with GATA4), NPPA/ANP/ANF and MYH7/beta-MHC (By similarity). Involved in the regulation of adult hippocampal neurogenesis. Involved in BDNF-driven pro-survival signaling in hippocampal adult-born neurons. Involved in the formation of long-term spatial memory and long-term potentiation (By similarity). In cochlear nucleus neurons, may play a role in deafferentation-induced apoptosis during the developmental critical period, when auditory neurons depend on afferent input for survival (By similarity). Binds to and activates the BACE1/Beta-secretase 1 promoter, hence may regulate the proteolytic processing of the amyloid precursor protein (APP) (PubMed:25663301). Plays a role in adipocyte differentiation (PubMed:11997522). May be involved in myoblast differentiation into myotubes (PubMed:17213202). Binds the consensus DNA sequence 5'-GGAAAAT-3' (Probable). In the presence of CREBBP, activates TNF transcription (PubMed:11514544). Binds to PPARG gene promoter and regulates its activity (PubMed:11997522). Binds to PPARG and REG3G gene promoters (By similarity)","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q14934/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NFATC4","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/NFATC4","total_profiled":1310},"omim":[{"mim_id":"609618","title":"NONCODING REPRESSOR OF NFAT; NRON","url":"https://www.omim.org/entry/609618"},{"mim_id":"608431","title":"G3BP STRESS GRANULE ASSEMBLY FACTOR 1; G3BP1","url":"https://www.omim.org/entry/608431"},{"mim_id":"602699","title":"NUCLEAR FACTOR OF ACTIVATED T CELLS, CYTOPLASMIC, CALCINEURIN-DEPENDENT 4; NFATC4","url":"https://www.omim.org/entry/602699"},{"mim_id":"602698","title":"NUCLEAR FACTOR OF ACTIVATED T CELLS, CYTOPLASMIC, CALCINEURIN-DEPENDENT 3; NFATC3","url":"https://www.omim.org/entry/602698"},{"mim_id":"602229","title":"SRY-BOX 10; SOX10","url":"https://www.omim.org/entry/602229"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nuclear speckles","reliability":"Supported"},{"location":"Cytosol","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in many","driving_tissues":[],"url":"https://www.proteinatlas.org/search/NFATC4"},"hgnc":{"alias_symbol":["NFAT3"],"prev_symbol":[]},"alphafold":{"accession":"Q14934","domains":[{"cath_id":"2.60.40.340","chopping":"398-577","consensus_level":"high","plddt":92.331,"start":398,"end":577},{"cath_id":"2.60.40.10","chopping":"588-685","consensus_level":"high","plddt":93.7858,"start":588,"end":685}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q14934","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q14934-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q14934-F1-predicted_aligned_error_v6.png","plddt_mean":58.62},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NFATC4","jax_strain_url":"https://www.jax.org/strain/search?query=NFATC4"},"sequence":{"accession":"Q14934","fasta_url":"https://rest.uniprot.org/uniprotkb/Q14934.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q14934/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q14934"}},"corpus_meta":[{"pmid":"10537109","id":"PMC_10537109","title":"L-type calcium channels and GSK-3 regulate the activity of NF-ATc4 in hippocampal neurons.","date":"1999","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/10537109","citation_count":435,"is_preprint":false},{"pmid":"12370307","id":"PMC_12370307","title":"Targeted disruption of NFATc3, but not NFATc4, reveals an intrinsic defect in calcineurin-mediated cardiac hypertrophic growth.","date":"2002","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12370307","citation_count":218,"is_preprint":false},{"pmid":"11997522","id":"PMC_11997522","title":"Phosphorylation of NFATc4 by p38 mitogen-activated protein kinases.","date":"2002","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11997522","citation_count":145,"is_preprint":false},{"pmid":"12750314","id":"PMC_12750314","title":"NFATc3 and NFATc4 are required for cardiac development and mitochondrial function.","date":"2003","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/12750314","citation_count":121,"is_preprint":false},{"pmid":"15537643","id":"PMC_15537643","title":"The transcription factor NFAT3 mediates neuronal survival.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15537643","citation_count":102,"is_preprint":false},{"pmid":"20385772","id":"PMC_20385772","title":"Lipin 1 represses NFATc4 transcriptional activity in adipocytes to inhibit secretion of inflammatory factors.","date":"2010","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20385772","citation_count":97,"is_preprint":false},{"pmid":"10636885","id":"PMC_10636885","title":"Electrical stimulation of neonatal cardiac myocytes activates the NFAT3 and GATA4 pathways and up-regulates the adenylosuccinate synthetase 1 gene.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10636885","citation_count":94,"is_preprint":false},{"pmid":"11044444","id":"PMC_11044444","title":"Ras regulates NFAT3 activity in cardiac myocytes.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11044444","citation_count":89,"is_preprint":false},{"pmid":"20173049","id":"PMC_20173049","title":"NFATc4 is negatively regulated in miR-133a-mediated cardiomyocyte hypertrophic repression.","date":"2010","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20173049","citation_count":83,"is_preprint":false},{"pmid":"25132256","id":"PMC_25132256","title":"Effect of Astragalus polysaccharides on expression of TNF-α, IL-1β and NFATc4 in a rat model of experimental colitis.","date":"2014","source":"Cytokine","url":"https://pubmed.ncbi.nlm.nih.gov/25132256","citation_count":77,"is_preprint":false},{"pmid":"17213202","id":"PMC_17213202","title":"RSK2 mediates muscle cell differentiation through regulation of NFAT3.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17213202","citation_count":64,"is_preprint":false},{"pmid":"24257415","id":"PMC_24257415","title":"NFAT3 and TGF-β/SMAD3 regulate the expression of miR-140 in osteoarthritis.","date":"2013","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/24257415","citation_count":61,"is_preprint":false},{"pmid":"19955386","id":"PMC_19955386","title":"Nuclear factor of activated T-cells isoform c4 (NFATc4/NFAT3) as a mediator of antiapoptotic transcription in NMDA receptor-stimulated cortical neurons.","date":"2009","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/19955386","citation_count":59,"is_preprint":false},{"pmid":"16219765","id":"PMC_16219765","title":"Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16219765","citation_count":53,"is_preprint":false},{"pmid":"22586092","id":"PMC_22586092","title":"Nuclear factor of activated T cells (NFATc4) is required for BDNF-dependent survival of adult-born neurons and spatial memory formation in the hippocampus.","date":"2012","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/22586092","citation_count":50,"is_preprint":false},{"pmid":"20101218","id":"PMC_20101218","title":"NFAT3 transcription factor inhibits breast cancer cell motility by targeting the Lipocalin 2 gene.","date":"2010","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/20101218","citation_count":49,"is_preprint":false},{"pmid":"31285763","id":"PMC_31285763","title":"Methylation of RCAN1.4 mediated by DNMT1 and DNMT3b enhances hepatic stellate cell activation and liver fibrogenesis through Calcineurin/NFAT3 signaling.","date":"2019","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/31285763","citation_count":47,"is_preprint":false},{"pmid":"15657420","id":"PMC_15657420","title":"Recruitment of the extracellular signal-regulated kinase/ribosomal S6 kinase signaling pathway to the NFATc4 transcription activation complex.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15657420","citation_count":47,"is_preprint":false},{"pmid":"23518069","id":"PMC_23518069","title":"Fenofibrate ameliorates cardiac hypertrophy by activation of peroxisome proliferator-activated receptor-α partly via preventing p65-NFκB binding to NFATc4.","date":"2013","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/23518069","citation_count":44,"is_preprint":false},{"pmid":"18354019","id":"PMC_18354019","title":"Deafferentation-induced activation of NFAT (nuclear factor of activated T-cells) in cochlear nucleus neurons during a developmental critical period: a role for NFATc4-dependent apoptosis in the CNS.","date":"2008","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/18354019","citation_count":44,"is_preprint":false},{"pmid":"32182216","id":"PMC_32182216","title":"NFATC4 promotes quiescence and chemotherapy resistance in ovarian cancer.","date":"2020","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/32182216","citation_count":41,"is_preprint":false},{"pmid":"16803872","id":"PMC_16803872","title":"NFAT3 is specifically required for TNF-alpha-induced cyclooxygenase-2 (COX-2) expression and transformation of Cl41 cells.","date":"2006","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/16803872","citation_count":41,"is_preprint":false},{"pmid":"18275974","id":"PMC_18275974","title":"T-type Ca2+ channel blockers prevent cardiac cell hypertrophy through an inhibition of calcineurin-NFAT3 activation as well as L-type Ca2+ channel blockers.","date":"2007","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/18275974","citation_count":40,"is_preprint":false},{"pmid":"18347059","id":"PMC_18347059","title":"Integration of protein kinases mTOR and extracellular signal-regulated kinase 5 in regulating nucleocytoplasmic localization of NFATc4.","date":"2008","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18347059","citation_count":39,"is_preprint":false},{"pmid":"38810124","id":"PMC_38810124","title":"The m7G Methyltransferase Mettl1 Drives Cardiac Hypertrophy by Regulating SRSF9-Mediated Splicing of NFATc4.","date":"2024","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/38810124","citation_count":38,"is_preprint":false},{"pmid":"22977251","id":"PMC_22977251","title":"Distinct activation properties of the nuclear factor of activated T-cells (NFAT) isoforms NFATc3 and NFATc4 in neurons.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22977251","citation_count":37,"is_preprint":false},{"pmid":"24948817","id":"PMC_24948817","title":"Modulation of GABAA receptor signaling increases neurogenesis and suppresses anxiety through NFATc4.","date":"2014","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/24948817","citation_count":36,"is_preprint":false},{"pmid":"19443652","id":"PMC_19443652","title":"NFAT-3 is a transcriptional repressor of the growth-associated protein 43 during neuronal maturation.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19443652","citation_count":34,"is_preprint":false},{"pmid":"32717288","id":"PMC_32717288","title":"Targeting NFATc4 attenuates non-alcoholic steatohepatitis in mice.","date":"2020","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/32717288","citation_count":34,"is_preprint":false},{"pmid":"22234350","id":"PMC_22234350","title":"Genetic polymorphisms of the transcription factor NFATc4 and development of new-onset diabetes after transplantation in Hispanic kidney transplant recipients.","date":"2012","source":"Transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/22234350","citation_count":33,"is_preprint":false},{"pmid":"30670969","id":"PMC_30670969","title":"SIRT6 Suppresses NFATc4 Expression and Activation in Cardiomyocyte Hypertrophy.","date":"2019","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30670969","citation_count":32,"is_preprint":false},{"pmid":"18086672","id":"PMC_18086672","title":"Interleukin-18 suppresses adiponectin expression in 3T3-L1 adipocytes via a novel signal transduction pathway involving ERK1/2-dependent NFATc4 phosphorylation.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18086672","citation_count":32,"is_preprint":false},{"pmid":"22198280","id":"PMC_22198280","title":"PPARα activation inhibits endothelin-1-induced cardiomyocyte hypertrophy by prevention of NFATc4 binding to GATA-4.","date":"2011","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/22198280","citation_count":32,"is_preprint":false},{"pmid":"27307045","id":"PMC_27307045","title":"Neuritin Up-regulates Kv4.2 α-Subunit of Potassium Channel Expression and Affects Neuronal Excitability by Regulating the Calcium-Calcineurin-NFATc4 Signaling Pathway.","date":"2016","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27307045","citation_count":31,"is_preprint":false},{"pmid":"27893713","id":"PMC_27893713","title":"Phosphorylation of NFAT3 by CDK3 induces cell transformation and promotes tumor growth in skin cancer.","date":"2016","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/27893713","citation_count":30,"is_preprint":false},{"pmid":"21606195","id":"PMC_21606195","title":"Opposing roles of FoxP1 and Nfat3 in transcriptional control of cardiomyocyte hypertrophy.","date":"2011","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/21606195","citation_count":30,"is_preprint":false},{"pmid":"31539560","id":"PMC_31539560","title":"Lercanidipine boosts the efficacy of mesenchymal stem cell therapy in 3-NP-induced Huntington's disease model rats via modulation of the calcium/calcineurin/NFATc4 and Wnt/β-catenin signalling pathways.","date":"2019","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/31539560","citation_count":28,"is_preprint":false},{"pmid":"34474091","id":"PMC_34474091","title":"Pterostilbene attenuates RIPK3-dependent hepatocyte necroptosis in alcoholic liver disease via SIRT2-mediated NFATc4 deacetylation.","date":"2021","source":"Toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/34474091","citation_count":27,"is_preprint":false},{"pmid":"23852416","id":"PMC_23852416","title":"Up-regulation of NFATc4 involves in neuronal apoptosis following intracerebral hemorrhage.","date":"2013","source":"Cellular and molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/23852416","citation_count":27,"is_preprint":false},{"pmid":"20718735","id":"PMC_20718735","title":"Activation of a nuclear factor of activated T-lymphocyte-3 (NFAT3) by oxidative stress in carboplatin-mediated renal apoptosis.","date":"2010","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/20718735","citation_count":27,"is_preprint":false},{"pmid":"18668201","id":"PMC_18668201","title":"Repression of NFAT3 transcriptional activity by estrogen receptors.","date":"2008","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/18668201","citation_count":26,"is_preprint":false},{"pmid":"26235896","id":"PMC_26235896","title":"Transcriptional Profiling of Hypoxic Neural Stem Cells Identifies Calcineurin-NFATc4 Signaling as a Major Regulator of Neural Stem Cell Biology.","date":"2015","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/26235896","citation_count":26,"is_preprint":false},{"pmid":"11514544","id":"PMC_11514544","title":"Requirement of two NFATc4 transactivation domains for CBP potentiation.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11514544","citation_count":24,"is_preprint":false},{"pmid":"16055480","id":"PMC_16055480","title":"Constrictor-induced translocation of NFAT3 in human and rat pulmonary artery smooth muscle.","date":"2005","source":"American journal of physiology. Lung cellular and molecular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16055480","citation_count":24,"is_preprint":false},{"pmid":"34192554","id":"PMC_34192554","title":"NFATc4 mediates ethanol-triggered hepatocyte senescence.","date":"2021","source":"Toxicology letters","url":"https://pubmed.ncbi.nlm.nih.gov/34192554","citation_count":23,"is_preprint":false},{"pmid":"19784808","id":"PMC_19784808","title":"Doxorubicin-mediated apoptosis in glioma cells requires NFAT3.","date":"2009","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/19784808","citation_count":22,"is_preprint":false},{"pmid":"29977601","id":"PMC_29977601","title":"Controllability in an islet specific regulatory network identifies the transcriptional factor NFATC4, which regulates Type 2 Diabetes associated genes.","date":"2018","source":"NPJ systems biology and applications","url":"https://pubmed.ncbi.nlm.nih.gov/29977601","citation_count":22,"is_preprint":false},{"pmid":"17108007","id":"PMC_17108007","title":"Involvement of oxidants and AP-1 in angiotensin II-activated NFAT3 transcription factor.","date":"2006","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17108007","citation_count":21,"is_preprint":false},{"pmid":"15272022","id":"PMC_15272022","title":"A ternary complex of transcription factors, Nishéd and NFATc4, and co-activator p300 bound to an intronic sequence, intronic regulatory element, is pivotal for the up-regulation of myosin light chain-2v gene in cardiac hypertrophy.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15272022","citation_count":21,"is_preprint":false},{"pmid":"25090113","id":"PMC_25090113","title":"L-carnitine protects against carboplatin-mediated renal injury: AMPK- and PPARα-dependent inactivation of NFAT3.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25090113","citation_count":20,"is_preprint":false},{"pmid":"26056815","id":"PMC_26056815","title":"KMUP-1 Attenuates Endothelin-1-Induced Cardiomyocyte Hypertrophy through Activation of Heme Oxygenase-1 and Suppression of the Akt/GSK-3β, Calcineurin/NFATc4 and RhoA/ROCK Pathways.","date":"2015","source":"Molecules (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/26056815","citation_count":19,"is_preprint":false},{"pmid":"17522069","id":"PMC_17522069","title":"Direct evidence for the critical role of NFAT3 in benzo[a]pyrene diol-epoxide-induced cell transformation through mediation of inflammatory cytokine TNF induction in mouse epidermal Cl41 cells.","date":"2007","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/17522069","citation_count":19,"is_preprint":false},{"pmid":"16273547","id":"PMC_16273547","title":"Immunolocalization of NFATc4 in the adult mouse brain.","date":"2005","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/16273547","citation_count":18,"is_preprint":false},{"pmid":"29180489","id":"PMC_29180489","title":"Downregulation of NFAT3 Due to Lack of T-Box Transcription Factor TBX5 Is Crucial for Cytokine Expression in T Cells.","date":"2017","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/29180489","citation_count":17,"is_preprint":false},{"pmid":"24583134","id":"PMC_24583134","title":"Interleukin-13-induced MUC5AC expression is regulated by a PI3K-NFAT3 pathway in mouse tracheal epithelial cells.","date":"2014","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/24583134","citation_count":17,"is_preprint":false},{"pmid":"29225169","id":"PMC_29225169","title":"Inhibition of Orai1-mediated Ca2+ entry limits endothelial cell inflammation by suppressing calcineurin-NFATc4 signaling pathway.","date":"2017","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/29225169","citation_count":16,"is_preprint":false},{"pmid":"22686291","id":"PMC_22686291","title":"Dopamine D1 receptors regulate type 1 inositol 1,4,5-trisphosphate receptor expression via both AP-1- and NFATc4-mediated transcriptional processes.","date":"2012","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22686291","citation_count":16,"is_preprint":false},{"pmid":"31379853","id":"PMC_31379853","title":"Nfatc4 Deficiency Attenuates Ototoxicity by Suppressing Tnf-Mediated Hair Cell Apoptosis in the Mouse Cochlea.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31379853","citation_count":15,"is_preprint":false},{"pmid":"19026640","id":"PMC_19026640","title":"Regulation of the stability and transcriptional activity of NFATc4 by ubiquitination.","date":"2008","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/19026640","citation_count":15,"is_preprint":false},{"pmid":"20852920","id":"PMC_20852920","title":"BNIP3 induces IL6 and calcineurin/NFAT3 hypertrophic-related pathways in H9c2 cardiomyoblast cells.","date":"2010","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20852920","citation_count":15,"is_preprint":false},{"pmid":"16475165","id":"PMC_16475165","title":"Knockdown of NFAT3 blocked TPA-induced COX-2 and iNOS expression, and enhanced cell transformation in Cl41 cells.","date":"2006","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16475165","citation_count":15,"is_preprint":false},{"pmid":"23597509","id":"PMC_23597509","title":"Regulation of type 1 IP₃ receptor expression by dopamine D2-like receptors via AP-1 and NFATc4 activation.","date":"2013","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/23597509","citation_count":15,"is_preprint":false},{"pmid":"25663301","id":"PMC_25663301","title":"Transcriptional regulation of BACE1 by NFAT3 leads to enhanced amyloidogenic processing.","date":"2015","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/25663301","citation_count":14,"is_preprint":false},{"pmid":"29467254","id":"PMC_29467254","title":"BDNF activates an NFI-dependent neurodevelopmental timing program by sequestering NFATc4.","date":"2018","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/29467254","citation_count":14,"is_preprint":false},{"pmid":"32805187","id":"PMC_32805187","title":"NULP1 Alleviates Cardiac Hypertrophy by Suppressing NFAT3 Transcriptional Activity.","date":"2020","source":"Journal of the American Heart Association","url":"https://pubmed.ncbi.nlm.nih.gov/32805187","citation_count":13,"is_preprint":false},{"pmid":"32488182","id":"PMC_32488182","title":"Extracellular vesicles produced by NFAT3-expressing cells hinder tumor growth and metastatic dissemination.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32488182","citation_count":13,"is_preprint":false},{"pmid":"24362677","id":"PMC_24362677","title":"Spatiotemporal changes in NFATc4 expression of retinal ganglion cells after light-induced damage.","date":"2013","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/24362677","citation_count":13,"is_preprint":false},{"pmid":"27155398","id":"PMC_27155398","title":"NFATc4 and myocardin synergistically up-regulate the expression of LTCC α1C in ET-1-induced cardiomyocyte hypertrophy.","date":"2016","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/27155398","citation_count":12,"is_preprint":false},{"pmid":"28760926","id":"PMC_28760926","title":"Distinct roles of NFATc1 and NFATc4 in human primary myoblast differentiation and in the maintenance of reserve cells.","date":"2017","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/28760926","citation_count":12,"is_preprint":false},{"pmid":"28992110","id":"PMC_28992110","title":"NFAT3/c4-mediated excitotoxicity in hippocampal apoptosis during radiation-induced brain injury.","date":"2017","source":"Journal of radiation research","url":"https://pubmed.ncbi.nlm.nih.gov/28992110","citation_count":12,"is_preprint":false},{"pmid":"37310791","id":"PMC_37310791","title":"Calcineurin regulates aldosterone production via dephosphorylation of NFATC4.","date":"2023","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/37310791","citation_count":11,"is_preprint":false},{"pmid":"25422138","id":"PMC_25422138","title":"Increased expression of NF-AT3 and NF-AT4 in the atria correlates with procollagen I carboxyl terminal peptide and TGF-β1 levels in serum of patients with atrial fibrillation.","date":"2014","source":"BMC cardiovascular disorders","url":"https://pubmed.ncbi.nlm.nih.gov/25422138","citation_count":11,"is_preprint":false},{"pmid":"31789412","id":"PMC_31789412","title":"Inhibition of calcineurin/NFATc4 signaling attenuates ventilator‑induced lung injury.","date":"2019","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/31789412","citation_count":10,"is_preprint":false},{"pmid":"24905014","id":"PMC_24905014","title":"NFAT1 and NFAT3 cooperate with HDAC4 during regulation of alternative splicing of PMCA isoforms in PC12 cells.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24905014","citation_count":10,"is_preprint":false},{"pmid":"25514788","id":"PMC_25514788","title":"Novel role for NFAT3 in ERK-mediated regulation of CXCR4.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25514788","citation_count":9,"is_preprint":false},{"pmid":"17194453","id":"PMC_17194453","title":"Tissue type-specific modulation of ER transcriptional activity by NFAT3.","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17194453","citation_count":9,"is_preprint":false},{"pmid":"28849081","id":"PMC_28849081","title":"Lercanidipine attenuates angiotensin II-induced cardiomyocyte hypertrophy by blocking calcineurin-NFAT3 and CaMKII-HDAC4 signaling.","date":"2017","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/28849081","citation_count":9,"is_preprint":false},{"pmid":"25758355","id":"PMC_25758355","title":"Na(+)/H (+) exchanger isoform 1 induced osteopontin expression in cardiomyocytes involves NFAT3/Gata4.","date":"2015","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25758355","citation_count":9,"is_preprint":false},{"pmid":"29288061","id":"PMC_29288061","title":"The effect of brain-derived neurotrophic factor on radiation-induced neuron architecture impairment is associated with the NFATc4/3 pathway.","date":"2017","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/29288061","citation_count":9,"is_preprint":false},{"pmid":"28577190","id":"PMC_28577190","title":"17β-Estradiol and/or estrogen receptor alpha blocks isoproterenol-induced calcium accumulation and hypertrophy via GSK3β/PP2A/NFAT3/ANP pathway.","date":"2017","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28577190","citation_count":8,"is_preprint":false},{"pmid":"29637744","id":"PMC_29637744","title":"The group VIA calcium-independent phospholipase A2 and NFATc4 pathway mediates IL-1β-induced expression of chemokines CCL2 and CXCL10 in rat fibroblasts.","date":"2018","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/29637744","citation_count":8,"is_preprint":false},{"pmid":"38639863","id":"PMC_38639863","title":"NFATc4 Knockout Promotes Neuroprotection and Retinal Ganglion Cell Regeneration After Optic Nerve Injury.","date":"2024","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/38639863","citation_count":7,"is_preprint":false},{"pmid":"21472269","id":"PMC_21472269","title":"Adrenergic receptor blockade-induced regression of pressure-overload cardiac hypertrophy is associated with inhibition of the calcineurin/NFAT3/GATA4 pathway.","date":"2010","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/21472269","citation_count":7,"is_preprint":false},{"pmid":"29670896","id":"PMC_29670896","title":"Short-Term Treatment with Esmolol Reverses Left Ventricular Hypertrophy in Adult Spontaneously Hypertensive Rats via Inhibition of Akt/NF-κB and NFATc4.","date":"2018","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/29670896","citation_count":7,"is_preprint":false},{"pmid":"33149757","id":"PMC_33149757","title":"Cardiac CaMKIIδ and Wenxin Keli Prevents Ang II-Induced Cardiomyocyte Hypertrophy by Modulating CnA-NFATc4 and Inflammatory Signaling Pathways in H9c2 Cells.","date":"2020","source":"Evidence-based complementary and alternative medicine : eCAM","url":"https://pubmed.ncbi.nlm.nih.gov/33149757","citation_count":6,"is_preprint":false},{"pmid":"29926655","id":"PMC_29926655","title":"[Effects of hydrogen sulfide (H2S) on cardiac hypertrophy and miRNA-133a-mediated Ca2+/calcineurin/NFATc4 signal pathway in rats].","date":"2018","source":"Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29926655","citation_count":6,"is_preprint":false},{"pmid":"21792994","id":"PMC_21792994","title":"Capillary electrophoretic mobility shift assay for binding of DNA with NFAT3, a transcription factor from H9c2 cardiac myoblast cells.","date":"2011","source":"Electrophoresis","url":"https://pubmed.ncbi.nlm.nih.gov/21792994","citation_count":6,"is_preprint":false},{"pmid":"35332122","id":"PMC_35332122","title":"CAMTA1-PPP3CA-NFATc4 multi-protein complex mediates the resistance of colorectal cancer to oxaliplatin.","date":"2022","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/35332122","citation_count":5,"is_preprint":false},{"pmid":"31486013","id":"PMC_31486013","title":"Involvement of calcineurin/NFATc4 pathway in a single-prolonged stress-based rat model of post-traumatic stress disorder.","date":"2019","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/31486013","citation_count":5,"is_preprint":false},{"pmid":"16645724","id":"PMC_16645724","title":"Involvement of nuclear factor of activated T cells 3 (NFAT3) in cyclin D1 induction by B[a]PDE or B[a]PDE and ionizing radiation in mouse epidermal Cl 41 cells.","date":"2006","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16645724","citation_count":4,"is_preprint":false},{"pmid":"16718377","id":"PMC_16718377","title":"NFAT3 is required for EGF-induced COX-2 transcription, but neither iNOS transcription nor cell transformation in Cl 41 cells.","date":"2006","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16718377","citation_count":4,"is_preprint":false},{"pmid":"37753338","id":"PMC_37753338","title":"How does NFAT3 regulate the occurrence of cardiac hypertrophy?","date":"2023","source":"International journal of cardiology. Heart & vasculature","url":"https://pubmed.ncbi.nlm.nih.gov/37753338","citation_count":3,"is_preprint":false},{"pmid":"32982770","id":"PMC_32982770","title":"Inhibition of the NFATc4/ERK/AKT Pathway and Improvement of Thiol-Specific Oxidative Stress by Dronedarone Possibly Secondary to the Reduction of Blood Pressure in an Animal Model of Ventricular Hypertrophy.","date":"2020","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/32982770","citation_count":3,"is_preprint":false},{"pmid":"23390317","id":"PMC_23390317","title":"p85α mediates NFAT3-dependent VEGF induction in the cellular UVB response.","date":"2013","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/23390317","citation_count":3,"is_preprint":false},{"pmid":"21081043","id":"PMC_21081043","title":"[Expression and significance of COX-2 and its transcription factors NFAT3 and c-Jun in non-small cell lung cancer].","date":"2010","source":"Zhongguo fei ai za zhi = Chinese journal of lung cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21081043","citation_count":3,"is_preprint":false},{"pmid":"40843009","id":"PMC_40843009","title":"Ginsenoside Rb1 ameliorates post-doxorubicin treatment myocardial hypertrophy via CaN/NFATc4/GATA4.","date":"2025","source":"Journal of ginseng research","url":"https://pubmed.ncbi.nlm.nih.gov/40843009","citation_count":2,"is_preprint":false},{"pmid":"40495950","id":"PMC_40495950","title":"Multi-parameter magnetic resonance imaging of zebularine in liver fibrosis treatment and calcineurin/NFAT3 mechanism.","date":"2025","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/40495950","citation_count":2,"is_preprint":false},{"pmid":"37006873","id":"PMC_37006873","title":"4'‑O‑methylbavachalcone inhibits succinate induced cardiomyocyte hypertrophy via the NFATc4 pathway.","date":"2023","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37006873","citation_count":2,"is_preprint":false},{"pmid":"39077755","id":"PMC_39077755","title":"NFAT3-FasL axis synchronously regulates apoptosis and necroptosis in murine cochlear outer hair cells after noise trauma.","date":"2024","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/39077755","citation_count":2,"is_preprint":false},{"pmid":"14990015","id":"PMC_14990015","title":"[CaN-NFAT3 signal pathway: a crucial hinge relates Ca2+ signal with cardiomyocyte hypertrophy].","date":"2004","source":"Zhonghua nei ke za zhi","url":"https://pubmed.ncbi.nlm.nih.gov/14990015","citation_count":2,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":53054,"output_tokens":10225,"usd":0.156269},"stage2":{"model":"claude-opus-4-6","input_tokens":14328,"output_tokens":6273,"usd":0.342697},"total_usd":0.498966,"stage1_batch_id":"msgbatch_012ZiiCUBfB62NCTQd4Bk1Jo","stage2_batch_id":"msgbatch_01Xuqq9aUHoQouS7UVGZNStZ","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"NFATc4 undergoes calcineurin-dependent nuclear translocation in hippocampal neurons in response to electrical activity or K+ depolarization, specifically requiring calcium entry through L-type voltage-gated calcium channels. GSK-3 phosphorylates NFATc4, promoting its nuclear export and antagonizing NFATc4-dependent transcription. NFATc4 controls expression of the inositol 1,4,5-trisphosphate receptor type 1 gene.\",\n      \"method\": \"Live imaging of NFATc4-GFP translocation in neurons, pharmacological inhibition of L-type channels, GSK-3 kinase assays, calcineurin inhibitor (cyclosporin A/FK506) treatment, reporter gene assays\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (imaging, pharmacology, kinase assay, reporter), replicated across stimulation conditions, highly cited foundational paper\",\n      \"pmids\": [\"10537109\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"p38 MAP kinase phosphorylates NFATc4 at multiple residues including Ser168 and Ser170 within the NFAT homology domain. Phosphorylation at these sites promotes cytoplasmic retention; Ala168/170 substitutions promote nuclear localization, increase NFAT-mediated transcription, and drive adipocyte differentiation by activating PPARγ2 gene expression via direct NFAT binding elements in the PPARγ2 promoter.\",\n      \"method\": \"In vitro kinase assay, site-directed mutagenesis, stable cell line expression, reporter assays, adipocyte differentiation assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro kinase assay combined with mutagenesis and functional cellular readouts in a single study\",\n      \"pmids\": [\"11997522\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"NFATc4 contains two distinct transactivation domains (N-terminal and C-terminal) that each interact with separate regions of the coactivator CBP (KIX and CH3 domains respectively). Both transactivation domains are required for CBP-mediated potentiation of NFATc4 transcriptional activity; removal of either domain abolishes CBP potentiation.\",\n      \"method\": \"Co-immunoprecipitation, deletion mutagenesis, reporter gene assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reciprocal binding mapped to defined domains with mutagenesis and functional transcription assays\",\n      \"pmids\": [\"11514544\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The ERK/RSK signaling pathway is recruited to the NFATc4-DNA transcription complex. RSK phosphorylates NFATc4 at Ser676, potentiating NFATc4 DNA binding by increasing NFAT-DNA association. ERK also targets Ser676 but interacts with NFATc4 at a distinct region from RSK.\",\n      \"method\": \"DNA affinity isolation, in-gel kinase assay, in vitro phosphorylation, mutagenesis, reporter assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro kinase assay with site-specific mutagenesis and DNA-binding measurement, single rigorous paper\",\n      \"pmids\": [\"15657420\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"RSK2 directly interacts with NFATc4 (via N-terminal aa 1-68 and C-terminal aa 416-674 kinase domains of RSK2 binding to aa 261-365 of NFAT3). Upon calcium ionophore stimulation, RSK2 induces nuclear localization of NFATc4 and phosphorylates NFATc4 in vitro (Km = 3.559 µM). RSK2/NFATc4 signaling drives skeletal muscle cell differentiation into multinucleated myotubes.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay, domain mapping, siRNA knockdown, C2C12 differentiation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro kinase assay, domain-level interaction mapping, functional differentiation phenotype with siRNA validation\",\n      \"pmids\": [\"17213202\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"mTOR phosphorylates the gate-keeping residues Ser168/170 of NFATc4, maintaining it in the cytoplasm at rest. ERK5 MAP kinase also mediates rephosphorylation of Ser168/170 and promotes NFATc4 nuclear export; ERK5-mediated phosphorylation primes subsequent phosphorylation by CK1α. Ablation of ERK5 in Erk5−/− cells causes defects in NFATc4 rephosphorylation and nucleocytoplasmic shuttling.\",\n      \"method\": \"Phospho-specific monoclonal antibody, kinetic phosphorylation analysis, Erk5−/− cell lines, mTOR inhibition (rapamycin), in vitro kinase assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — phospho-specific antibody combined with genetic Erk5 knockout validation and kinase assays\",\n      \"pmids\": [\"18347059\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"GSK-3β promotes NFATc4 ubiquitination through Lys48-linked polyubiquitin chains, decreasing NFATc4 protein levels and transcriptional activity. GSK-3β-induced phosphorylation and ubiquitination represses NFATc4-dependent cardiac gene expression.\",\n      \"method\": \"Ubiquitination assay, proteasome inhibitor treatment, GSK-3β activation/inhibition, reporter assays, Western blot\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct ubiquitination demonstrated with mechanistic follow-up, single lab\",\n      \"pmids\": [\"19026640\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Lipin 1 represses NFATc4 transcriptional activity through direct protein-protein interaction and is recruited to NFATc4 target gene promoters in vivo. Catalytically active and inactive lipin 1 both suppress NFATc4, and the suppression may involve recruitment of histone deacetylases. Loss of lipin 1 in adipocytes increases expression of NFATc4 targets including TNFα, resistin, FABP4, and PPARγ.\",\n      \"method\": \"Co-immunoprecipitation, chromatin immunoprecipitation (ChIP), reporter assays, siRNA knockdown, lipin 1-deficient (fld) mouse tissue analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, ChIP, genetic mouse model, multiple orthogonal methods\",\n      \"pmids\": [\"20385772\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"NFATc4 and NFATc3 form complexes that are required redundantly for cardiac development; NFATc4 constitutively active form rescues ventricular myocyte proliferation, compact zone density, trabecular formation, and cardiac mitochondrial complex II enzymatic activity in nfatc3−/−nfatc4−/− double-knockout embryos.\",\n      \"method\": \"Genetic double knockout, cardiac-specific transgenic rescue, mitochondrial enzyme activity assays, electron microscopy\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with functional rescue, mitochondrial enzymatic readout\",\n      \"pmids\": [\"12750314\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"NFATc4 (NFAT3) interacts with estrogen receptor alpha and beta in a ligand-independent manner, binding specifically to the AF-1 domain of ERβ. NFATc4 acts as a co-activator of both ERα and ERβ, enhancing their transcriptional activities and increasing NFAT3 binding of ERα to the estrogen-responsive element.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation in mammalian cells, in vitro binding assay, ChIP, reporter assays, siRNA knockdown\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — yeast two-hybrid confirmed by Co-IP and in vitro binding, domain mapping, ChIP, multiple methods\",\n      \"pmids\": [\"16219765\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"FoxP1 forms a complex with Nfat3 (NFATc4) in cardiomyocytes, visualized by bimolecular fluorescence complementation (BiFC). Calcineurin activation induces FoxP1-Nfat3 complex formation. FoxP1 represses Nfat3-activated hypertrophy-associated genes (Myh7, Rcan1, Cx43, Anf, Bnp) and activates genes maintaining normal heart function (Myh6, p57Kip2). Co-occupancy of FoxP1 and Nfat3 at hypertrophy gene promoters is demonstrated in vivo.\",\n      \"method\": \"BiFC, amino acid substitution mutagenesis at interaction interface, ChIP in neonatal and adult heart tissue, reporter assays, cardiomyocyte hypertrophy phenotyping\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — BiFC with mutagenesis validation, ChIP in native tissue, multiple orthogonal methods\",\n      \"pmids\": [\"21606195\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"IL-18 induces ERK1/2-dependent phosphorylation of NFATc4 at Ser676, promoting NFATc4 nuclear translocation and in vivo DNA binding to the adiponectin promoter NFAT binding site, thereby suppressing adiponectin transcription in 3T3-L1 adipocytes.\",\n      \"method\": \"Reporter assay with NFAT site mutation, in vivo DNA binding assay, ERK1/2 inhibitors (U0126, PD98059), ERK1/2 siRNA, NFATc4 siRNA knockdown\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic pathway defined with promoter mutagenesis, kinase inhibitors, and two siRNA knockdown targets\",\n      \"pmids\": [\"18086672\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"NFATc4 (Nishéd-binding partner) forms a ternary complex with the transcription factor Nishéd and co-activator p300 at an intronic regulatory element (IRE) of the MLC-2v gene. Angiotensin II stimulation enhances this complex formation and MLC-2v transcription; losartan (AT1 antagonist) abolishes it.\",\n      \"method\": \"Gel mobility shift assay, co-immunoprecipitation, reporter assays, pharmacological antagonism\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — ternary complex identified by EMSA and Co-IP with functional reporter validation, single lab\",\n      \"pmids\": [\"15272022\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"NFATc4 is a transcriptional repressor of GAP-43 in neurons. Prior to neurotrophin activation, endogenous NFATc4 occupies the GAP-43 promoter in PC-12 cells, cultured neurons, and mouse brain. Overexpression of NFATc4 represses GAP-43 activation by neurotrophin signaling, and NFATc4 is required to repress GAP-43 and other pro-axon outgrowth genes during specific developmental windows.\",\n      \"method\": \"ChIP in vitro and in vivo, reporter assays, overexpression, promoter in silico analysis validated experimentally\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP in vivo and in vitro, overexpression with functional readout, multiple cellular systems\",\n      \"pmids\": [\"19443652\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"NFATc4 knockdown induces apoptosis in cortical neurons even under survival conditions. NFATc4 mediates NMDAR-dependent neuronal survival by regulating transcription from BDNF promoter IV; NFATc4 inhibition reduces BDNF expression, and exogenous BDNF rescues the pro-apoptotic effects of NFATc4 inhibition.\",\n      \"method\": \"RNAi knockdown, dominant-negative NFAT expression, reporter assays with BDNF promoter IV, neuronal apoptosis assays\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with defined molecular pathway, rescue experiment, multiple neuronal models\",\n      \"pmids\": [\"19955386\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"NFATc4 calcineurin-dependent activity is specifically required for survival of adult-born hippocampal neurons in response to BDNF signaling. Cyclosporin A injection or TrkB-Fc (BDNF scavenger) reduces adult-born neuron survival in WT but not NFATc4−/− mice. Loss of NFATc4 leads to selective defects in LTP and spatial memory encoding.\",\n      \"method\": \"NFATc4 knockout mice, stereotaxic drug delivery, calcineurin inhibition, TrkB-Fc scavenger, hippocampal neurogenesis quantification, LTP electrophysiology, spatial memory behavioral testing\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockout with multiple orthogonal functional readouts (survival, LTP, behavior), BDNF pathway placed upstream\",\n      \"pmids\": [\"22586092\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"NFATc4 activation properties in neurons differ from NFATc3: NFATc4 requires prolonged (1-3 h) depolarization for nuclear translocation whereas NFATc3 translocates rapidly. The serine-proline repeat region of NFATc4 is critical for its activation magnitude. GSK3β suppression is specifically required for NFATc4 nuclear import upon depolarization.\",\n      \"method\": \"NFATc3/NFATc4 chimera analysis, siRNA knockdown, GSK3β inhibition, live imaging of nuclear translocation in hippocampal and DRG neurons, p38 and mTOR inhibition\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — domain chimeras with live imaging, genetic knockdown, pharmacological dissection of multiple kinases\",\n      \"pmids\": [\"22977251\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"NFAT3 directly binds to specific DNA sequences within the BACE1 promoter and activates BACE1 transcription; NFATc4 overexpression increases BACE1 promoter activity, BACE1 protein expression, and Aβ production.\",\n      \"method\": \"ChIP, luciferase reporter assays, overexpression, siRNA knockdown\",\n      \"journal\": \"Neurochemical research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — ChIP with reporter validation, single lab\",\n      \"pmids\": [\"25663301\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"NFAT3 directly regulates miR-140 transcription in OA chondrocytes by binding to the miR-140 regulatory sequence, acting as a transcriptional activator. TGF-β/SMAD3 acts as a repressor. TGF-β interferes with NFAT3 translocation, thereby suppressing miR-140 expression. These roles were established by mutagenesis, ChIP, and siRNA knockdown.\",\n      \"method\": \"ChIP, promoter mutagenesis, siRNA knockdown, immunocytochemistry, reporter assays\",\n      \"journal\": \"Arthritis research & therapy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP with mutagenesis validation, siRNA knockdown, multiple methods in single study\",\n      \"pmids\": [\"24257415\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"NFATc4 drives hippocampal progenitor neurogenesis via the calcineurin/NFATc4 axis. NFATc4 directly regulates GABRA2 and GABRA4 subunit expression by binding to specific promoter responsive elements. GABAAR signaling promotes neurogenesis through NFATc4, and NFATc4-dependent increase in neurogenesis is required for suppression of anxiety response.\",\n      \"method\": \"Genome-wide ChIP, luciferase reporter assays, calcineurin inhibition (cyclosporin A), NFATc4−/− mice, behavioral anxiety testing, pharmacological GABAAR modulation\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide ChIP with promoter validation, genetic knockout, behavioral readout\",\n      \"pmids\": [\"24948817\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"CDK3 directly interacts with NFATc4 (by mammalian two-hybrid assay) and phosphorylates NFATc4 at Ser259, enhancing its transactivation activity. Mutation of Ser259 to Ala reduces NFATc4-dependent colony formation and xenograft tumor growth.\",\n      \"method\": \"Mammalian two-hybrid assay, in vitro phosphorylation/kinase assay, site-directed mutagenesis (S259A), soft agar colony formation, xenograft mouse model\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro phosphorylation, mutagenesis validated in vitro and in vivo, two-hybrid interaction\",\n      \"pmids\": [\"27893713\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"NFATc4 is recruited to the Kv4.2 gene promoter and is required for neuritin-induced Kv4.2 transcriptional upregulation. The Ca2+/calcineurin/NFATc4 axis mediates neuritin-induced potentiation of IA densities in cerebellar granule neurons; these effects are absent in Nfatc4−/− but not Nfatc2−/− mice.\",\n      \"method\": \"ChIP, luciferase reporter assays, calcineurin inhibition, Nfatc4−/− mice, electrophysiology, AAV-mediated neuritin overexpression\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP with reporter validation, genetic knockout with isoform specificity, functional electrophysiology\",\n      \"pmids\": [\"27307045\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"BDNF sequesters NFATc4 in extranuclear Golgi compartments, thereby derepressing an NFI-dependent temporal gene program in cerebellar granule cells. This extranuclear sequestration reveals an autoregulatory loop as Bdnf itself is part of the NFI target program.\",\n      \"method\": \"Subcellular fractionation/localization, Golgi co-localization, gene expression analysis, NFATc4 loss-of-function\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — novel localization mechanism with functional gene expression consequence, single lab\",\n      \"pmids\": [\"29467254\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SIRT6, via its deacetylase activity, suppresses NFATc4 expression and activation in cardiomyocytes; SIRT6 interacts with NFATc4, likely facilitating its deacetylation. SIRT6 overexpression elevates NFATc4 phosphorylation, prevents nuclear accumulation, and suppresses transcriptional activity, while deacetylase-dead SIRT6 (H133Y mutant) has no effect.\",\n      \"method\": \"Co-immunoprecipitation, adenoviral overexpression, deacetylase-dead mutant (H133Y), Western blot, immunofluorescence, siRNA knockdown, reporter assays\",\n      \"journal\": \"Frontiers in pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — Co-IP with deacetylase-dead mutant control, functional hypertrophy readout, single lab\",\n      \"pmids\": [\"30670969\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"RCAN1.4 overexpression alleviates liver fibrosis through inhibition of calcineurin/NFAT3 (NFATc4) signaling. Downregulation of RCAN1.4 by DNMT1- and DNMT3b-mediated DNA methylation of its promoter relieves inhibition of calcineurin, activating NFATc4 and promoting HSC activation and fibrogenesis.\",\n      \"method\": \"Bisulfite sequencing PCR, ChIP for DNMT1/DNMT3b, rAAV8-mediated RCAN1.4 overexpression, CaN activity assays, siRNA knockdown, CCl4 mouse fibrosis model\",\n      \"journal\": \"Theranostics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic pathway defined with ChIP for methyltransferases, genetic overexpression in vivo, multiple orthogonal methods\",\n      \"pmids\": [\"31285763\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"NFATc4 directly binds to PPARα in the nucleus and negatively regulates its transcriptional activity, impairing hepatic fatty acid oxidation and increasing lipid deposition in NASH. NFATc4 activation also increases osteopontin (OPN) secretion from hepatocytes, driving macrophage-mediated inflammation and hepatic stellate cell fibrosis via paracrine signaling.\",\n      \"method\": \"NFATc4 knockdown (gain/loss of function), co-immunoprecipitation (NFATc4-PPARα), reporter assays, OPN secretion measurement, paracrine co-culture experiments, NASH mouse model\",\n      \"journal\": \"Journal of hepatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP of direct protein interaction, genetic knockdown with defined molecular mechanism, in vivo model\",\n      \"pmids\": [\"32717288\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"NULP1 directly interacts with NFATc4 via its topologically associating domain (TAD) through the C-terminal region of NULP1, suppressing NFATc4 transcriptional activity. NULP1 knockout exacerbates cardiac hypertrophy, rescued by NFAT pathway inhibition with VIVIT peptides.\",\n      \"method\": \"Co-immunoprecipitation (domain mapping), NULP1 knockout/transgenic mice, VIVIT peptide treatment, aortic banding model, reporter assays\",\n      \"journal\": \"Journal of the American Heart Association\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP with domain mapping, genetic knockout with pharmacological rescue, in vivo model\",\n      \"pmids\": [\"32805187\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"NFATc4 nuclear translocation and pathway activation drives quiescence (G0 arrest) and chemotherapy resistance in ovarian cancer cells, in part via downregulation of MYC. Cisplatin treatment triggers NFATc4 nuclear translocation; inhibition of NFATc4 increases chemotherapy response both in vitro and in vivo.\",\n      \"method\": \"NFATc4 overexpression/inhibition, flow cytometry for cell cycle, cisplatin response assays, in vivo xenograft, MYC expression analysis\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — functional loss/gain-of-function with mechanistic link to MYC, validated in vivo, single lab\",\n      \"pmids\": [\"32182216\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"SIRT2-mediated deacetylation of NFATc4 inhibits its nuclear translocation. In ethanol-exposed hepatocytes, PTS (pterostilbene) rescues SIRT2 expression, which deacetylates NFATc4 and prevents its nuclear translocation; NFATc4 overexpression impairs the ability of PTS to suppress RIPK3 expression and necroptosis.\",\n      \"method\": \"NFATc4 overexpression/knockdown, SIRT2 siRNA knockdown, immunofluorescence for NFATc4 nuclear localization, Western blot for acetylation status, RIPK3 expression\",\n      \"journal\": \"Toxicology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — indirect deacetylation evidence via pathway inhibition, single lab, mechanistic follow-up incomplete\",\n      \"pmids\": [\"34474091\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NFATc4 triggers hepatocyte senescence via repression of PPARγ in ethanol-treated hepatocytes. NFATc4 knockdown protected against ethanol-induced senescence markers (SA-β-gal, p16, p21, HMGA1, γH2AX), and PPARγ deficiency abrogated these protective effects.\",\n      \"method\": \"NFATc4 siRNA knockdown, PPARγ knockdown, SA-β-gal staining, Western blot for senescence markers, in vivo mouse alcoholic liver model\",\n      \"journal\": \"Toxicology letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — epistasis through double knockdown, in vivo validation, single lab\",\n      \"pmids\": [\"34192554\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"PPP3CA (calcineurin catalytic subunit) and CAMTA1 competitively bind to NFATc4; CAMTA1 knockdown promotes PPP3CA-mediated dephosphorylation of NFATc4, activating it and promoting colorectal cancer chemoresistance. NFATc4 knockdown reverses chemoresistance caused by CAMTA1 knockdown.\",\n      \"method\": \"Co-immunoprecipitation, NFATc4 knockdown, CAMTA1 overexpression/knockdown, xenograft mouse model, oxaliplatin resistance assays\",\n      \"journal\": \"Cell death discovery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — competitive Co-IP with functional epistasis, in vivo xenograft validation\",\n      \"pmids\": [\"35332122\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Calcineurin (protein phosphatase 3) dephosphorylates NFATc4 in adrenal zona glomerulosa cells. Phosphoproteomics identified NFATc4 as a calcineurin substrate. ZG-specific deletion of the calcineurin regulatory subunit CnB1 reduces Cyp11b2 expression. NFATc4 directly binds the CYP11B2 (aldosterone synthase) promoter via ChIP, and constitutively active NFATc4 increases CYP11B2 expression; NFATc4 deletion impairs K+-dependent aldosterone synthesis.\",\n      \"method\": \"Phosphoproteomics, ZG-specific CnB1 knockout mice, NFATc4 knockout, constitutively active NFATc4 expression, ChIP for CYP11B2 promoter, aldosterone secretion assays\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — phosphoproteomics identifies substrate, ChIP confirms direct promoter binding, two genetic models validate the pathway\",\n      \"pmids\": [\"37310791\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Mettl1-catalyzed m7G modification of SRSF9 mRNA increases SRSF9 expression, which then promotes alternative splicing and stabilization of NFATc4, thereby activating cardiac hypertrophy. SRSF9 knockdown protects against TAC- or Mettl1-induced cardiac hypertrophy. YY1 acts as a transcription factor for Mettl1 during cardiac hypertrophy.\",\n      \"method\": \"Mettl1 knockout/overexpression, SRSF9 knockdown, alternative splicing analysis, TAC and Ang II mouse models, m7G modification profiling\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss/gain-of-function in vivo with mechanistic link to mRNA splicing/stability, single recent study\",\n      \"pmids\": [\"38810124\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"PPARα activation by fenofibrate enhances association of PPARα with NFATc4 in the nucleus, competing with and decreasing NFATc4 interaction with GATA-4, thereby reducing transactivation of the BNP gene and inhibiting cardiomyocyte hypertrophy.\",\n      \"method\": \"EMSA, co-immunoprecipitation, PPARα siRNA knockdown, reporter assays, confocal microscopy, primary neonatal rat cardiomyocytes\",\n      \"journal\": \"Archives of biochemistry and biophysics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — EMSA and Co-IP with siRNA validation, multiple methods in single lab\",\n      \"pmids\": [\"22198280\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"NFATc4 interacts with myocardin to synergistically activate LTCC α1C (L-type Ca2+ channel) gene expression in ET-1-induced cardiomyocyte hypertrophy. NFATc4 also directly activates myocardin expression by binding to its promoter.\",\n      \"method\": \"Co-immunoprecipitation, ChIP, reporter assays, NFATc4 and myocardin overexpression/knockdown\",\n      \"journal\": \"Life sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — Co-IP and ChIP in same study, single lab\",\n      \"pmids\": [\"27155398\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"TBX5 transcription factor binds to the NFAT3 promoter and is required for NFAT3 expression; mutation of the TBX5 binding site in the NFAT3 promoter diminishes promoter activity, while TBX5 overexpression enhances NFAT3 expression. TBX5-mediated NFAT3 expression suppresses IL-2 transcription, establishing TBX5 as a transcriptional regulator of NFAT3 in T cells. NFAT3 suppresses IL-2 promoter activity through its N-terminal transactivation domain, Ca2+-regulatory domain, and DNA-binding domain.\",\n      \"method\": \"Promoter mutagenesis, reporter assays, TBX5 overexpression in CD4+ T cells, siRNA knockdown, chromatin accessibility analysis\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — promoter mutagenesis with functional rescue, domain mapping using chimeras, single lab\",\n      \"pmids\": [\"29180489\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Orai1-dependent Ca2+ entry activates calcineurin-NFATc4 signaling specifically in endothelial cells; among all NFAT isoforms, TNFα exclusively triggers NFATc4 nuclear accumulation in HUVECs. Orai1 knockdown prevents TNFα-induced NFATc4 nuclear translocation and reduces ICAM-1 and VCAM-1 expression.\",\n      \"method\": \"Orai1 knockdown/overexpression, NFATc4 overexpression, calcineurin inhibition, nuclear translocation imaging, ICAM-1/VCAM-1 expression, in vivo mouse aorta\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — isoform-specific nuclear translocation validated with multiple tools, in vivo confirmation\",\n      \"pmids\": [\"29225169\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"NFATc4 deficiency in cochlear hair cells attenuates ototoxic drug-induced apoptosis. NFATc4 is activated and translocates from cytoplasm to nucleus in response to ototoxic drugs, followed by increased Tnf expression and downstream apoptosis pathway activation. Nfatc4-deficient hair cells show reduced TNF-mediated apoptosis.\",\n      \"method\": \"Nfatc4−/− mice, ototoxic drug treatment, immunofluorescence for NFATc4 localization, Western blot for Tnf and downstream apoptosis markers, hearing function tests\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockout with defined NFATc4-Tnf-apoptosis pathway, functional hearing readout\",\n      \"pmids\": [\"31379853\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"NFATc4 knockout (but not NFATc3 knockout) increases retinal ganglion cell (RGC) survival, improves retinal function, and delays axonal degeneration after optic nerve crush. NFATc4 up-regulation after injury immunolocalizes to the ganglion cell layer. Lentiviral re-introduction of NFATc4 into NFATc4−/− retinas reverses the pro-survival effect, confirming NFATc4-dependent pro-apoptotic signaling (involving caspase-3).\",\n      \"method\": \"NFATc4−/− and NFATc3−/− mice, optic nerve crush model, lentiviral NFATc4 delivery, microarray, immunostaining for cleaved caspase-3, retinal function assessment\",\n      \"journal\": \"Molecular neurobiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockout with isoform specificity confirmed by rescue experiment, multiple functional readouts\",\n      \"pmids\": [\"38639863\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"miR-133a directly targets two conserved base-pairing sites in the NFATc4 3'-UTR, negatively regulating NFATc4 expression. Mutation of both sites in the NFATc4 3'-UTR completely blocks miR-133a-mediated repression. miR-133a reduces endogenous NFATc4 protein and attenuates hypertrophic stimulus-induced NFATc4 upregulation.\",\n      \"method\": \"Luciferase reporter with 3'-UTR, 3'-UTR site-directed mutagenesis, miR-133a gain-of-function, miR-133a inhibitor treatment, Western blot\",\n      \"journal\": \"American journal of physiology. Heart and circulatory physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — 3'-UTR mutagenesis confirms direct targeting, gain- and loss-of-function both performed\",\n      \"pmids\": [\"20173049\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NFATc4 is a calcium-regulated transcription factor that resides in the cytoplasm in a hyperphosphorylated, inactive state; upon elevation of intracellular Ca2+, calcineurin dephosphorylates NFATc4 (including key gate-keeping residues Ser168/170), driving its nuclear translocation where it activates or represses target genes (including Kv4.2, GABRA2/4, BNP, GAP-43, CYP11B2, BACE1, PPARγ2, LTCC α1C, and FasL) by interacting with co-factors such as CBP (via dual transactivation domain contacts), GATA-4, myocardin, FoxP1, PPARα, lipin 1, NULP1, and estrogen receptors; multiple kinases (GSK-3, p38, mTOR, ERK5, ERK1/2/RSK, CDK3) rephosphorylate NFATc4 to promote its nuclear export or ubiquitin-proteasome-mediated degradation, while post-translational modifications including SIRT2/SIRT6-mediated deacetylation and Mettl1/SRSF9-regulated alternative splicing further modulate its activity, enabling NFATc4 to function as a context-dependent regulator of cardiac hypertrophy, neuronal survival/apoptosis, adult hippocampal neurogenesis, aldosterone synthesis, and metabolic liver disease.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"NFATc4 is a calcium/calcineurin-regulated transcription factor that integrates diverse extracellular signals to control gene expression programs in the heart, brain, immune cells, adipocytes, and liver. In resting cells, NFATc4 is maintained in the cytoplasm by phosphorylation at gate-keeping residues Ser168/170 by kinases including p38, mTOR, ERK5, and GSK-3β; calcium influx through L-type channels or store-operated Orai1 channels activates calcineurin, which dephosphorylates NFATc4 to drive its nuclear translocation, where it activates or represses target genes (including BDNF, Kv4.2, GABRA2/4, CYP11B2, BACE1, PPARγ2, BNP, and GAP-43) through cooperation with cofactors such as CBP, GATA-4, FoxP1, myocardin, and estrogen receptors [PMID:10537109, PMID:11997522, PMID:18347059, PMID:11514544, PMID:21606195]. Nuclear export and degradation are enforced by rephosphorylation cascades (GSK-3β/ERK5/CK1α priming, RSK/ERK1/2 at Ser676, CDK3 at Ser259) and by GSK-3β-triggered K48-linked polyubiquitination, while SIRT2- and SIRT6-mediated deacetylation and Mettl1/SRSF9-dependent alternative splicing provide additional regulatory layers [PMID:19026640, PMID:15657420, PMID:27893713, PMID:30670969, PMID:38810124]. NFATc4 functions as a context-dependent survival or apoptotic effector—promoting BDNF-dependent adult hippocampal neurogenesis and spatial memory, yet driving caspase-3-dependent apoptosis in retinal ganglion cells and cochlear hair cells after injury—and is required redundantly with NFATc3 for cardiac development [PMID:22586092, PMID:38639863, PMID:31379853, PMID:12750314].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Established that NFATc4 is a calcium/calcineurin-dependent transcription factor in neurons, resolving how electrical activity is coupled to nuclear gene regulation: L-type calcium channel entry triggers calcineurin-dependent nuclear translocation, while GSK-3 opposes this by phosphorylating NFATc4 to promote export.\",\n      \"evidence\": \"Live imaging of NFATc4-GFP in hippocampal neurons with pharmacological inhibition of L-type channels, calcineurin inhibitors, and GSK-3 kinase assays\",\n      \"pmids\": [\"10537109\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the specific GSK-3 phosphorylation sites on NFATc4 not mapped\", \"Downstream neuronal target gene program not characterized genome-wide\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Defined how NFATc4 engages transcriptional coactivators: dual transactivation domains (N- and C-terminal) contact distinct regions of CBP (KIX and CH3 domains), and both contacts are required for transcriptional potentiation.\",\n      \"evidence\": \"Co-immunoprecipitation with deletion mutagenesis and reporter gene assays\",\n      \"pmids\": [\"11514544\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of dual-domain CBP engagement unknown\", \"Whether other NFAT family members share this bipartite mechanism not tested\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Identified Ser168/170 as critical gate-keeping phosphorylation sites: p38 MAPK phosphorylates these residues to enforce cytoplasmic retention, and their mutation to alanine constitutively activates NFATc4, driving PPARγ2 expression and adipocyte differentiation.\",\n      \"evidence\": \"In vitro kinase assay, site-directed mutagenesis, adipocyte differentiation assays\",\n      \"pmids\": [\"11997522\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether p38 is the dominant kinase at Ser168/170 in all tissues not resolved\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Revealed that ERK/RSK signaling potentiates NFATc4 activity by phosphorylating Ser676, which enhances DNA binding rather than promoting export—establishing a pro-activating kinase input distinct from the export-promoting kinases.\",\n      \"evidence\": \"DNA affinity isolation, in-gel kinase assay, Ser676 mutagenesis, reporter assays\",\n      \"pmids\": [\"15657420\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How Ser676 phosphorylation structurally enhances DNA binding is unknown\", \"Relative contributions of ERK versus RSK at Ser676 in vivo not quantified\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Expanded NFATc4's cofactor repertoire beyond CBP: NFATc4 interacts with estrogen receptors α and β in a ligand-independent manner, functioning as a coactivator of ER-dependent transcription.\",\n      \"evidence\": \"Yeast two-hybrid confirmed by Co-IP, in vitro binding, ChIP, and reporter assays\",\n      \"pmids\": [\"16219765\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"ER–NFATc4 target genes in physiological contexts not identified\", \"In vivo relevance in estrogen-responsive tissues not demonstrated\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"RSK2 was identified as a direct NFATc4 interactor with defined binding domains, showing that RSK2-mediated phosphorylation promotes nuclear localization and drives skeletal muscle differentiation.\",\n      \"evidence\": \"Co-IP with domain mapping, in vitro kinase assay (Km determined), siRNA knockdown, C2C12 myotube differentiation\",\n      \"pmids\": [\"17213202\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether RSK2 phosphorylates the same Ser676 or additional sites not fully resolved\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Delineated the rephosphorylation cascade at Ser168/170: mTOR maintains basal phosphorylation, while ERK5 rephosphorylates these sites after calcineurin-driven dephosphorylation and primes CK1α-mediated sequential phosphorylation to enforce nuclear export.\",\n      \"evidence\": \"Phospho-specific antibody, Erk5−/− cells, rapamycin inhibition, in vitro kinase assays\",\n      \"pmids\": [\"18347059\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether additional kinases contribute to Ser168/170 rephosphorylation in specific tissues\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Established that GSK-3β not only promotes NFATc4 nuclear export but also targets it for K48-linked polyubiquitination and proteasomal degradation, adding protein turnover as a regulatory layer.\",\n      \"evidence\": \"Ubiquitination assays with proteasome inhibitors, GSK-3β activation/inhibition, reporter assays\",\n      \"pmids\": [\"19026640\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"The E3 ubiquitin ligase mediating GSK-3β-triggered NFATc4 degradation is unidentified\", \"Ubiquitination sites on NFATc4 not mapped\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Demonstrated that NFATc4 functions as a transcriptional repressor at the GAP-43 promoter in neurons and as a survival factor via BDNF promoter IV activation—establishing its dual activator/repressor function depending on target gene context.\",\n      \"evidence\": \"ChIP in PC-12 cells, cultured neurons, and mouse brain for GAP-43; RNAi knockdown with BDNF rescue for neuronal survival\",\n      \"pmids\": [\"19443652\", \"19955386\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which NFATc4 switches between activation and repression at different promoters is unknown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"miR-133a was identified as a direct post-transcriptional repressor of NFATc4 via two conserved sites in its 3′-UTR, providing a microRNA-based mechanism that limits NFATc4 protein levels during cardiac hypertrophy.\",\n      \"evidence\": \"3′-UTR luciferase reporter with site-directed mutagenesis, miR-133a gain- and loss-of-function\",\n      \"pmids\": [\"20173049\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether other miRNAs cooperatively regulate NFATc4 not explored\", \"In vivo cardiac hypertrophy rescue by miR-133a-mediated NFATc4 suppression not tested\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Lipin 1 was identified as a direct nuclear repressor of NFATc4 transcriptional activity via protein–protein interaction at target gene promoters, revealing a metabolic enzyme as a transcriptional corepressor of NFATc4 in adipocytes.\",\n      \"evidence\": \"Co-IP, ChIP at target promoters, siRNA knockdown, fld (lipin 1-deficient) mouse tissue\",\n      \"pmids\": [\"20385772\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether lipin 1 enzymatic activity contributes independently from its scaffold function remains debated\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"FoxP1 was shown to form a calcineurin-dependent complex with NFATc4 at hypertrophy gene promoters in cardiomyocytes, functioning as a repressive partner that redirects NFATc4 from hypertrophic to homeostatic gene programs.\",\n      \"evidence\": \"BiFC visualization, mutagenesis at interaction interface, ChIP in neonatal and adult heart tissue\",\n      \"pmids\": [\"21606195\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How the FoxP1–NFATc4 complex discriminates between hypertrophic and homeostatic promoters\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"PPARα was found to compete with GATA-4 for NFATc4 binding in cardiomyocytes, suppressing BNP transactivation and hypertrophy—revealing cofactor competition as a mechanism for modulating NFATc4 output.\",\n      \"evidence\": \"EMSA, Co-IP, PPARα siRNA knockdown, reporter assays in neonatal rat cardiomyocytes\",\n      \"pmids\": [\"22198280\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis for PPARα–NFATc4 versus GATA-4–NFATc4 competition is unknown\", \"In vivo confirmation in cardiac tissue not provided\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"NFATc4 was established as essential for adult hippocampal neurogenesis and spatial memory: BDNF/TrkB-calcineurin-NFATc4 signaling selectively supports survival of adult-born neurons, and NFATc4 knockout impairs LTP and memory.\",\n      \"evidence\": \"NFATc4−/− mice, stereotaxic cyclosporin A and TrkB-Fc delivery, hippocampal neurogenesis quantification, LTP electrophysiology, behavioral spatial memory testing\",\n      \"pmids\": [\"22586092\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream transcriptional targets mediating NFATc4-dependent neuronal survival in the adult hippocampus not fully defined\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Clarified isoform-specific activation kinetics: NFATc4 requires prolonged depolarization (1–3 h) for nuclear translocation (unlike rapid NFATc3), the serine-proline repeat region determines activation magnitude, and GSK-3β suppression is specifically required for NFATc4 nuclear import.\",\n      \"evidence\": \"NFATc3/c4 chimera analysis, live imaging, GSK-3β inhibition, siRNA in hippocampal and DRG neurons\",\n      \"pmids\": [\"22977251\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for how the serine-proline repeat tunes activation threshold is unknown\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"NFATc3 and NFATc4 were shown to be redundantly required for cardiac development; double knockout is lethal with defects in myocyte proliferation, trabeculation, and mitochondrial complex II activity, all rescued by constitutively active NFATc4.\",\n      \"evidence\": \"Genetic double knockout, cardiac-specific transgenic rescue, mitochondrial enzyme assays, electron microscopy\",\n      \"pmids\": [\"12750314\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional targets mediating mitochondrial complex II regulation not identified\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Genome-wide ChIP identified GABRA2 and GABRA4 as direct NFATc4 target genes in hippocampal progenitors, linking GABA receptor signaling to calcineurin-NFATc4-dependent adult neurogenesis and anxiety-related behavior.\",\n      \"evidence\": \"Genome-wide ChIP, luciferase reporters, NFATc4−/− mice, behavioral anxiety tests, pharmacological GABAAR modulation\",\n      \"pmids\": [\"24948817\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full set of NFATc4 direct targets in hippocampal progenitors beyond GABRA genes not catalogued\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"CDK3 was identified as a direct NFATc4 kinase at Ser259 that enhances transactivation and promotes cell transformation, expanding NFATc4 regulation to cell cycle kinases and oncogenic contexts.\",\n      \"evidence\": \"Mammalian two-hybrid, in vitro kinase assay, S259A mutagenesis, colony formation, xenograft model\",\n      \"pmids\": [\"27893713\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CDK3-NFATc4 axis is active in non-transformed cells not established\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"NFATc4 was shown to be specifically required (not NFATc2) for neuritin-induced Kv4.2 channel transcription in cerebellar granule neurons, establishing isoform-specific transcriptional control of neuronal excitability.\",\n      \"evidence\": \"ChIP at Kv4.2 promoter, Nfatc4−/− versus Nfatc2−/− mice, electrophysiology, AAV-neuritin\",\n      \"pmids\": [\"27307045\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Broader ion channel gene program regulated by NFATc4 in cerebellum not mapped\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"BDNF was found to sequester NFATc4 in Golgi compartments rather than the nucleus, derepressing an NFI-dependent gene program—revealing a non-canonical extranuclear mechanism of NFATc4 regulation.\",\n      \"evidence\": \"Subcellular fractionation, Golgi co-localization, gene expression analysis in cerebellar granule cells\",\n      \"pmids\": [\"29467254\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of Golgi retention is unknown\", \"Generalizability beyond cerebellar granule cells not tested\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"SIRT6 deacetylase activity was shown to suppress NFATc4 nuclear accumulation and transcriptional activity in cardiomyocytes, adding lysine acetylation as a regulatory modification controlling NFATc4 localization.\",\n      \"evidence\": \"Co-IP, deacetylase-dead H133Y mutant, adenoviral overexpression, siRNA knockdown, reporter assays\",\n      \"pmids\": [\"30670969\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Specific acetylated lysine residues on NFATc4 not identified\", \"Whether SIRT6 directly deacetylates NFATc4 or acts indirectly not definitively resolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"NFATc4 deficiency protects cochlear hair cells from ototoxic drug-induced apoptosis via reduced TNF expression, establishing NFATc4 as a pro-apoptotic transcription factor in sensory cells.\",\n      \"evidence\": \"Nfatc4−/− mice, ototoxic drug treatment, immunofluorescence, hearing function tests\",\n      \"pmids\": [\"31379853\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct binding of NFATc4 to the Tnf promoter in hair cells not demonstrated by ChIP\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"NFATc4 was established as a driver of NASH pathogenesis through dual mechanisms: direct binding to and inhibition of PPARα transcriptional activity (impairing fatty acid oxidation) and osteopontin-mediated paracrine activation of macrophages and stellate cells.\",\n      \"evidence\": \"Co-IP of NFATc4–PPARα, OPN secretion assays, paracrine co-culture, NASH mouse model\",\n      \"pmids\": [\"32717288\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"NFATc4 target genes beyond PPARα and OPN in hepatocytes not catalogued\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"NULP1 was identified as a direct NFATc4-interacting repressor whose loss exacerbates cardiac hypertrophy—rescued by NFAT pathway inhibition—adding another nuclear cofactor that restrains NFATc4 output.\",\n      \"evidence\": \"Co-IP with domain mapping, NULP1 knockout/transgenic mice, VIVIT peptide rescue, aortic banding model\",\n      \"pmids\": [\"32805187\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which NULP1 inhibits NFATc4 transactivation not resolved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"SIRT2-mediated deacetylation was shown to inhibit NFATc4 nuclear translocation in hepatocytes, and NFATc4 represses PPARγ to drive ethanol-induced hepatocyte senescence, linking NFATc4 to alcoholic liver disease.\",\n      \"evidence\": \"SIRT2 siRNA, NFATc4 overexpression/knockdown, PPARγ epistasis, senescence markers, alcoholic liver mouse model\",\n      \"pmids\": [\"34474091\", \"34192554\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct deacetylation of NFATc4 by SIRT2 not confirmed by in vitro deacetylation assay\", \"NFATc4 acetylation sites remain unmapped\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Phosphoproteomics identified NFATc4 as a calcineurin substrate in adrenal zona glomerulosa cells; NFATc4 directly binds the CYP11B2 promoter and is required for potassium-stimulated aldosterone synthesis, establishing a new physiological role in mineralocorticoid regulation.\",\n      \"evidence\": \"Phosphoproteomics, ZG-specific CnB1 knockout, NFATc4 knockout, ChIP at CYP11B2 promoter, aldosterone secretion assays\",\n      \"pmids\": [\"37310791\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether NFATc4 cooperates with other transcription factors at CYP11B2 not defined\", \"Contribution of NFATc4 to primary aldosteronism not tested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Mettl1-catalyzed m7G modification of SRSF9 mRNA was shown to increase SRSF9, which promotes alternative splicing and stabilization of NFATc4 transcript, activating cardiac hypertrophy—revealing an epitranscriptomic input to NFATc4 regulation.\",\n      \"evidence\": \"Mettl1 knockout/overexpression, SRSF9 knockdown, alternative splicing analysis, TAC and Ang II mouse models\",\n      \"pmids\": [\"38810124\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Specific NFATc4 splice variants generated by SRSF9 not characterized\", \"Whether this mechanism operates outside the heart is unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"NFATc4 (but not NFATc3) knockout was shown to promote retinal ganglion cell survival and delay axonal degeneration after optic nerve crush, with lentiviral re-introduction reversing the protective effect—confirming isoform-specific pro-apoptotic function in the retina via caspase-3.\",\n      \"evidence\": \"NFATc4−/− and NFATc3−/− mice, optic nerve crush, lentiviral rescue, microarray, caspase-3 immunostaining\",\n      \"pmids\": [\"38639863\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional targets of NFATc4 driving RGC apoptosis not identified\", \"Whether NFATc4 inhibition is therapeutically viable for glaucoma not tested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Major unresolved questions include: the identity of the E3 ubiquitin ligase(s) targeting NFATc4, the specific lysine residues subject to acetylation/deacetylation, the structural basis for cofactor selectivity (activator vs. repressor), and the complete genome-wide target gene repertoire across tissues.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"E3 ligase for NFATc4 ubiquitination unknown\", \"Acetylation sites unmapped\", \"No structural model of NFATc4 with any cofactor\", \"Comprehensive tissue-specific cistrome lacking\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 2, 7, 9, 10, 13, 14, 17, 18, 19, 21, 25, 31, 34, 35]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [3, 13, 17, 18, 19, 21, 31]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 1, 3, 5, 9, 10, 16, 25, 27]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 1, 5, 16]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [22]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 3, 5, 6, 11, 20, 36]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [2, 7, 9, 10, 13, 14, 17, 18, 19, 21, 25, 31, 34, 35]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [14, 37, 38]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [8]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [0, 15, 16, 19, 21]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"CBP\",\n      \"GATA4\",\n      \"FOXP1\",\n      \"PPP3CA\",\n      \"GSK3B\",\n      \"PPARA\",\n      \"LPIN1\",\n      \"ESR1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}